Patent Grant
10188467
The systems and methods disclosed herein relate generally to computer systems facilitating medical device guidance through tissue by a medical practitioner.
Various medical device systems are available to aid a healthcare provider to guide a medical device in a patient. The medical device systems can provide various image guidance cues to aid the healthcare provider, and can also provide views of images of an imaged region and of virtual medical devices corresponding to physical medical devices.
Implementations disclosed herein provide systems, methods, and apparatus for generating images facilitating medical device insertion into tissue by an operator. Certain embodiments pertain to a free-hand medical device guidance system. The system can provide the healthcare provider manual control over the medical device, while making the spatial relationships between the target, medical device and U/S image more intuitive via a visual display. Using this visual feedback, the operator can adjust the medical device's position, orientation, or trajectory. Certain of the contemplated embodiments can be used in conjunction with systems described in greater detail in U.S. patent application Ser. No. 13/014,587, filed Jan. 26, 2011, entitled SYSTEMS, METHODS, APPARATUSES, AND COMPUTER-READABLE MEDIA FOR IMAGE MANAGEMENT IN IMAGE-GUIDED MEDICAL PROCEDURES; U.S. patent application Ser. No. 13/753,274, filed Jan. 29, 2013, entitled MULTIPLE MEDICAL DEVICE GUIDANCE (the '274 Application); U.S. patent application Ser. No. 14/212,933, filed Mar. 14, 2014, entitled MEDICAL DEVICE GUIDANCE; and U.S. patent application Ser. No. 14/872,930, entitled AFFECTED REGION DISPLAY, filed Oct. 1, 2015; each of which is hereby incorporated herein by reference in its entirety.
The system can aid the healthcare provider in guiding one or more medical devices through the tissue of the patient and/or placing the medical devices, and can be used for treatment of tumors, fibroids or cysts, with bipolar radiofrequency medical device ablation, multiple microwave medical devices, electroporation, and/or electrochemotherapy systems. It can also be used for nerve or muscle stimulation or sensing (electrodes in the spine, brain). The system can be used during open surgery, laparoscopic surgery, endoscopic procedures, biopsies, and/or interventional radiology procedures.
The system can be used in conjunction with live intraoperative ultrasound (U/S), pre-operative CT, or any cross-sectional medical imaging modality (e.g. MRI, OCT, etc.). In addition, the system can use a variety of techniques to determine the position and/or orientation of one or more medical devices. For example, the system can use the NDI Aurora magnetic system, the Ascension MedSafe system, NDI Polaris optical system, etc. In some embodiments, a position sensor can be embedded inside, or affixed to each medical device, at the tip, along the shaft, and/or on the handle. Sensors can be built into the medical devices or attached after manufacturing, as described in greater detail in U.S. application Ser. No. 14/212,184, filed Mar. 14, 2014, entitled SENSOR MOUNT, incorporated herein in its entirety.
Each medical device can be associated with one or more sensors, which can continually, or repeatedly, report position and/or orientation, or a single sensor can be used for all the medical devices. In embodiments where one sensor is used, the healthcare provider can attach the sensor to the particular medical device that she is intentionally repositioning, and then, once she has placed that medical device, she can remove the sensor and attach it to the next medical device she is repositioning. In some embodiments, the medical devices can be manipulated by the healthcare provider. In certain embodiments, the system can be used with a robotic manipulator, where the robot controls the medical devices.
In some embodiments, the handles of medical devices can have push-button switches, to allow the user to select a medical device, indicate a tissue target, etc. The handle can also have an indicator light to indicate to the users which medical device is selected. Finally, the handle can have an encoder to detect how much length of electrode has been exposed by the user, and report this information to the guidance system and therapeutic generator
Image Guidance Systems
In some embodiments, the position sensing unit 106 can track surgical instruments 112, 114, also referred to herein as medical devices 112, 114, within a tracking area and provide data to the image guidance unit 104. The medical devices 112, 114 can include invasive medical devices, such as, but not limited to, biopsy needles, ablation needles, surgical needles, nerve-block needles, or other needles, electrocautery device, catheters, stents, laparoscopes or laparoscopic cameras, ultrasound transducers, or other instruments that enter a part of the body, and non-invasive medical devices that do not enter the body, such as, but not limited to, ultrasound transducers, probes, or other external imaging devices, etc. The medical devices 112, 114 can also include medical imaging devices that provide or aid in the selection of medical images for display. In some embodiments, the medical imaging device can be any device that is used to select a particular medical image for display. The medical imaging devices can include invasive medical devices, such as laparoscopic cameras, and non-invasive medical devices, such as external ultrasound transducers.
Although only two surgical instruments 112, 114 are shown in
Information about and from multiple surgical systems 108 and attached surgical instruments 112 (and additional surgical instruments not shown) can be processed by image guidance unit 104 and shown on display 102. These and other possible embodiments are discussed in more detail below. It will be understood that any combination of the display objects, image guidance cues, etc., described herein can be displayed concurrently, or simultaneously. Further, reference to displaying objects “concurrently” and/or “simultaneously” is to be interpreted broadly and may refer to displaying objects in such a way that to a human observer the objects are visible at the same time.
Imager 110 can be communicatively coupled to image guidance unit 104. In some embodiments, imager 110 can be coupled to a second display unit (not shown). The second display unit can display imaging data from imager 110. The imaging data displayed on display 102 and displayed on second display unit can be the same or different. In some embodiments, the imager 110 can be an ultrasound machine 110, the medical device 114 can be a movable imaging unit, such as an ultrasound transducer 114 or ultrasound probe 114, and the second display unit can be a display associated with the ultrasound machine 110 that displays the ultrasound images from the ultrasound machine 110. In some embodiments, a movable imaging unit 114 can be communicatively coupled to image guidance unit 104. The movable imaging unit 114 can be useful for allowing a user to indicate what portions of a first set of imaging data are to be displayed. For example, the movable imaging unit 114 can be an ultrasound transducer 114, a needle or other medical device, for example, and can be used by a user to indicate what portions of imaging data, such as a pre-operative CT scan, to show on a display 102 as image 150. Further, in some embodiments, there can be a third set of pre-operative imaging data that can be displayed with the first set of imaging data.
In some embodiments, a navigation system comprises a display 102 and a position sensing unit 106 communicatively coupled to image guidance unit 104. In some embodiments, position sensing unit 106, display 102, and image guidance unit 104 are coupled to the stand 118. Image guidance unit 104 can be used to produce images 150 that are displayed on display 102. The images 150 produced on display 102 by the image guidance unit 104 can be determined based on ultrasound or other visual images from the first surgical instrument 112 and second surgical instrument 114.
In the illustrated embodiment, the image 150 includes a 2D viewing area 152 and a 3D viewing area 154 (which can also be referred to as a virtual 3D space) each of which includes various display objects. In the 2D viewing area, some or all of the display objects can be displayed as 2D objects. However, it will be understood that some of the display objects in the 2D viewing area can be displayed as 3D objects. In the 3D viewing area 154, some or all of the display objects are displayed as 3D objects. Furthermore, the display objects in the 3D viewing area can be displayed in a perspective based at least in part on a point-of-view location. In the illustrated embodiment, the display objects include, an image region 156 with an ultrasound image 157, a virtual medical device 158 corresponding to the first surgical instrument 112, a virtual imaging device 160 corresponding to the second surgical instrument 114, intersection indicator 162, trajectory indicator 164, variance volume indicator 166, and shaded region 168. It will be understood that any combination of the aforementioned display objects can be displayed in the 2D viewing area and/or 3D viewing area as desired.
As a non-limiting example, if the first surgical instrument 112 is an ablation needle 112 and the second surgical instrument 114 is an ultrasound probe 114, then images 150 produced on display 102 can include the images, or video, from the ultrasound probe 114 (e.g., image slice 156) combined with other medical display objects and image guidance cues, such as projected medical device drive (e.g., trajectory indicators 164) or projected ablation volume (not shown), determined based on the emplacement of ablation needle 112. If the first surgical instrument 112 is an ultrasound probe 112 and the second surgical instrument 114 is a laparoscopic camera 114, then images 150 produced on display 102 can include the video from the laparoscopic camera 114 combined with ultrasound data superimposed on the laparoscopic image. More surgical instruments can be added to the system. For example, the system can include an ultrasound probe, ablation needle, laparoscopic camera, stapler, cauterizer, scalpel and/or any other surgical instrument or medical device. The system can also process and/or display collected data, such as preoperative CT scans, X-Rays, MRIs, laser scanned 3D surfaces etc.
The term “emplacement” as used herein is a broad term and may refer to, without limitation, position and/or orientation or any other appropriate location information. The term “pose” as used herein is a broad term encompassing its plain and ordinary meaning and may refer to, without limitation, position and orientation or any other appropriate location information. In some embodiments, the imaging data obtained from one or both of surgical instruments 112 and 114 can include other modalities such as a CT scan, MRI, open-magnet MRI, optical coherence tomography (“OCT”), positron emission tomography (“PET”) scans, fluoroscopy, ultrasound, or other preoperative, or intraoperative 2D or 3D anatomical imaging data. In some embodiments, surgical instruments 112 and 114 can also be scalpels, implantable hardware, or any other device used in surgery. Any appropriate surgical system 108 or imager 110 can be communicatively coupled to the corresponding medical instruments 112 and 114.
As noted above, the images 150 produced can also be generated based on live, intraoperative, or real-time data obtained using the second surgical instrument 114, which is communicatively coupled to imager 110. The term “real time” as used herein is a broad term and has its ordinary and customary meaning, including without limitation instantaneously or nearly instantaneously. The use of the term real time can also mean that actions are performed or data is obtained with the intention to be used immediately, upon the next cycle of a system or control loop, or any other appropriate meaning. Additionally, as used herein, real-time data can be data that is obtained at a frequency that would allow a healthcare provider to meaningfully interact with the data during surgery. For example, in some embodiments, real-time data can be a medical image of a patient that is updated one time per second. In some embodiments, real-time data can be ultrasound data that is updated multiple times per second.
The surgical instruments 112, 114 can be communicatively coupled to the position sensing unit 106 (e.g., sensors embedded or coupled to the surgical instruments 112, 114 can be communicatively coupled with the position sensing unit 106). The position sensing unit 106 can be part of imager 110 or it can be separate. The position sensing unit 106 can be used to determine the emplacement of first surgical instrument 112 and/or the second surgical instrument 114. In some embodiments, the position sensing unit 106 can include a magnetic tracker and/or one or more magnetic coils can be coupled to surgical instruments 112 and/or 114. In some embodiments, the position sensing unit 106 can include an optical tracker and/or one or more visually-detectable fiducials can be coupled to surgical instruments 112 and/or 114. In some embodiments, the position sensing unit 106 can be located below the patient. In such embodiments, the position sensing unit 106 can be located on or below the table 120. For example, in embodiments where the position sensing unit 106 is a magnetic tracker, it can be mounted below the surgical table 120. Such an arrangement can be useful when the tracking volume of the position sensing unit 106 is dependent on the location of the position sensing unit 106, as with many magnetic trackers. In some embodiments, magnetic tracking coils can be mounted in or on the medical devices 112 and 114.
In some embodiments, the position sensing unit can determine one or more x, y, z coordinates and/or the quaternions (e.g., yaw, pitch, and/or roll) of device trackers associated with one or more of the medical devices 112, 114. In some embodiments, the position sensing unit 106 can be an electromagnetic measurement system (e.g., NDI Aurora system) using sensor coils for device trackers attached to the first and/or second surgical devices 112, 114. In some embodiments, the position sensing unit 106 can be an optical 3D tracking system using fiducials. Such optical 3D tracking systems can include the NDI Polaris Spectra, Vicra, Certus, PhaseSpace IMPULSE, Vicon MX, InterSense IS-900, NaturalPoint OptiTrack, Polhemus FastTrak, IsoTrak, or Claron MicronTracker2. In some embodiments, the position sensing unit 106 can each be an inertial 3D tracking system comprising a compass, accelerometer, tilt sensor, and/or gyro, such as the InterSense InertiaCube or the Nintendo Wii controller. In some embodiments, the position sensing unit 106 can be attached to or affixed on the corresponding surgical device 112 and 114.
In some embodiments, the position sensing units 106, can include sensing devices such as the HiBall tracking system, a GPS device, or signal emitting device that would allow for tracking of the position and/or orientation (e.g., emplacement) of the device tracker (also referred to as an emplacement sensor). In some embodiments, a position sensing unit 106 can be affixed to either or both of the surgical devices 112, 114. The surgical devices 112 or 114 can be tracked by the position sensing unit 106. A room coordinate system reference, such as the display 102 can also be tracked by the position sensing unit 106 in order to determine the emplacements of the surgical devices 112, 114 with respect to the room coordinate system. Devices 112, 114 can also include or have coupled thereto one or more accelerometers, which can be used to estimate movement, position, and location of the devices.
In some embodiments, the position sensing unit 106 can be an Ascension Flock of Birds, Nest of Birds, driveBAY, medSAFE, trakSTAR, miniBIRD, MotionSTAR, pciBIRD, or Calypso 2D Localization System and device trackers attached to the first and/or second medical devices 112, 114 can be magnetic tracking coils.
The term “device tracker” (also referred to as an emplacement sensor), as used herein, is a broad term encompassing its plain and ordinary meaning and includes without limitation all types of magnetic coils or other magnetic field sensing devices for use with magnetic trackers, fiducials or other optically detectable markers for use with optical trackers, such as those discussed above and below. In some embodiments, the device trackers can be implemented using optical position sensing devices, such as the HiBall tracking system and the position sensing unit 106 can form part of the HiBall tracking system. Device trackers can also include a GPS device or signal emitting device that allows for tracking of the position and/or orientation of the device tracker. In some embodiments, a signal emitting device might include a radio-frequency identifier (RFID). In such embodiments, the position sensing unit 106 can use the GPS coordinates of the device trackers or can, for example, triangulate the radio frequency signal being emitted by the RFID associated with device trackers. The tracking systems can also include one or more 3D mice.
Furthermore, the system 101 can use the emplacement data associated with the device trackers (e.g., received from the device trackers or from the position sensing unit 106) to determine other emplacement information, including, but not limited to the emplacement of a trajectory, an image plane, image region, imaged region, and/or one or more intersections, etc. The determined emplacement information can be used to generate and display the various image guidance cues, such as, but not limited to, the intersection indicator 162, the trajectory indicator 164, the variance volume 166, the shaded region 168, the image region 156 with the image 157, etc.
In some embodiments, the imaged region can correspond to the tissue or region that is imaged (area and/or volume) by the medical device 114. In some cases, the image plane can correspond to the plane at which the medical device 114 acquires an image and/or a plane in the virtual 3D space that is associated therewith. In certain cases, the image region can correspond to the region (area and/or volume) at which the medical device 114 acquires an image and/or to a region in the virtual 3D space associated therewith. For example, in some cases, image data acquired by the medical device 114 in the medical device's image region can be mapped to a corresponding virtual image region in the virtual 3D space. The image region may also be referred to as an image slice and/or image slab. Furthermore, in some embodiments, the image region can include at least a portion of the image plane.
The emplacement of the image plane, image region (area and/or volume), and/or imaged region can also be determined based at least in part on the operating parameters of the medical device 114. For example, the operating parameters can indicate what portion of the medical device 114 will capture an image (e.g., emit ultrasonic waves), as well as the dimensions of the image region and/or imaged region (e.g., height, width, and/or depth of the image that will be acquired), as well as the image region.
Images 150 can be produced based on intraoperative or real-time data obtained using first surgical instrument 112, which is coupled to first surgical system 108. In the illustrated embodiment of
In some embodiments, the display 102 displays 3D images to a user, such as a healthcare provider. Stereoscopic 3D displays separate the imagery shown to each of the user's eyes. This can be accomplished by a stereoscopic display, a lenticular auto-stereoscopic display, or any other appropriate type of display. The display 102 can be an alternating row or alternating column display. Example alternating row displays include the Miracube G240S, as well as Zalman Trimon Monitors. Alternating column displays include devices manufactured by Sharp, as well as many “auto-stereoscopic” displays (e.g., Philips). In some embodiments, Sony Panasonic 3D passive displays and LG, Samsung, and/or Vizio 3D TVs can be used as well. Display 102 can also be a cathode ray tube. Cathode Ray Tube (CRT) based devices, can use temporal sequencing, showing imagery for the left and right eye in temporal sequential alternation. This method can also be used projection-based devices, as well as by liquid crystal display (LCD) devices, light emitting diode (LED) devices, and/or organic LED (OLED) devices.
In certain embodiments, the display 102 can be a head mounted display (HMD) worn by the user in order to receive 3D images from the image guidance unit 104. In such embodiments, a separate display, such as the pictured display 102, can be omitted. The 3D graphics can be produced using underlying data models, stored in the image guidance unit 104 and projected onto one or more 2D planes in order to create left and right eye images for a head mount, lenticular, or other 3D display. The underlying 3D model can be updated based on the relative emplacements of the various devices 112 and 114, as determined by the position sensing unit(s) 106, and/or based on new data associated with the devices 112 and 114. For example, if the second medical device 114 is an ultrasound probe, then the underlying data model can be updated to reflect the most recent ultrasound image. If the first medical device 112 is an ablation needle, then the underlying model can be updated to reflect any changes related to the needle, such as power or duration information. Any appropriate 3D graphics processing can be used for rendering including processing based on OpenGL, Direct3D, Java 3D, etc. Whole, partial, or modified 3D graphics packages can also be used, such packages including 3DS Max, SolidWorks, Maya, Form Z, Cybermotion 3D, VTK, Slicer, or any others. In some embodiments, various parts of the needed rendering can occur on traditional or specialized graphics hardware. The rendering can also occur on the general CPU, on programmable hardware, on a separate processor, be distributed over multiple processors, over multiple dedicated graphics cards, or using any other appropriate combination of hardware or technique.
One or more components, units, devices, or elements of various embodiments can be packaged and/or distributed as part of a kit. For example, in one embodiment, an ablation needle, one or more device trackers, 3D viewing glasses, and/or a portion of an ultrasound wand can form a kit. Other embodiments can have different elements or combinations of elements grouped and/or packaged together. Kits can be sold or distributed separately from or with the other portions of the system.
One will readily recognize that there are numerous other examples of image guidance systems which can use, incorporate, support, or provide for the techniques, methods, processes, and systems described herein.
Depicting Surgical Instruments
It can often be difficult to discern the content of a 3D scene from a 2D depiction of it, or even from a 3D depiction of it. Therefore, various embodiments herein provide image guidance that can help the healthcare provider better understand the scene, relative emplacements or poses of objects in the scene and thereby provide improved image guidance.
Although only one virtual surgical instrument 202 is displayed, it will be understood that multiple medical devices can be tracked and displayed concurrently, or simultaneously, on screen 220, as described in greater detail in the '274 Application, previously incorporated by reference. For example, a virtual rendering of the medical imaging device 222 can be displayed.
The virtual surgical instrument 202 can be displayed in a virtual 3D space with the screen 220 acting as a window into the virtual 3D space. Thus, as the surgical instrument 242 is moved to the right with respect to a point-of-view location (e.g., the location of the point-of-view for viewing the 3D space), the virtual surgical instrument 202 can also move to the right. Similarly, if the surgical instrument 242 is rotated 90 degrees so that the tip of the surgical instrument is pointing away from the point-of-view location (e.g., at the screen 220), the virtual surgical instrument 201 will likewise show the change in orientation, and show the tip of the virtual surgical instrument 202 in the background and the other end of the virtual surgical instrument 202 in the foreground. In some embodiments, as described in greater detail in U.S. application Ser. No. 14/212,933, incorporated herein by reference in its entirety, the point-of-view location can be a fixed location, such as a predetermined distance/angle from the screen 220 or stand 118 and or a location configured by the user; or the point-of-view location can by dynamic. For example, the system can track a user in real-time and determine the point-of-view location based at least in part on the tracked location of the user.
Some models of medical devices have markings such as bands around the shaft (to indicate distance along the shaft), and a colored region 203 near the tip to indicate from where the radio frequency or microwave energy is emitted in the case of an ablation probe. Healthcare providers performing medical device procedures are often familiar with these markings and can use them to help understand the spatial relationship between the medical device and anatomy. In some embodiments, the make and model of the medical device 242 is known to the image guidance system and the virtual medical device 202 displayed in display 220 can resemble medical device 242. The features of medical devices that can be rendered in the scene include the overall shape (diameter, cross sectional shape, curvature, etc.), color, distance markers, visuals or echogenic fiduciary markers, the state of deployable elements such as tines, paddles, anchors, resection loops, stiffening or steerable sleeves, temperature, radiation, light or magnetic field sensors, lens, waveguides, fluid transfer channels, and the like.
The type of medical device being used can be input into the image guidance system 101, can be a system default, can be detected by a camera or other device, can be received as data from an attached medical device, such as surgical system 108 in
Consider an embodiment in which the virtual surgical instrument 202 in the display 220 is an ablation needle depicting the portion of the needle that will perform the ablation, for example, the portion that emits the radio or microwave energy. If the display 220 also includes ultrasound data, then the doctor can be able to find the tumor 212 she wishes to ablate by moving the ultrasound probe around until she spots the tumor 212. In various embodiments, she will be able to see the displayed ultrasound data and its location relative to the displayed medical device with the markings. She can then drive the medical device until she sees, on display 220, that the emitter-portion of the medical device encompasses the tumor in the ultrasound, also seen on display 220. When she activates the ablation, she can then be more certain that she has ablated the correct portion of the tissue. Various embodiments of this are discussed below.
As another example, consider the physical markings that can be on the instruments themselves. These markings can help orient a healthcare provider during use of the instrument. In some embodiments, the image guidance unit can represent these markings in the images displayed in the display. For example, certain ultrasound transducers are built with an orientation mark (e.g., a small bump) on one side of the transducing array. That mark can also be shown in the ultrasound image on the scanner's display, to help the healthcare provider understand where the scanned anatomical structures shown on screen are located under the transducer, inside the patient. In some embodiments, the image guidance system can display a symbolic 3D representation of the orientation mark both next to the motion-tracked ultrasound slice (e.g., moving with the displayed ultrasound slice) and next to the 2D view of the ultrasound slice also displayed by the system. An example of this is displayed in
It will be understood that an image slice or image slab can also refer to image data received from an imaging device, such as an ultrasound transponder. In some embodiments, the image data can correspond to a cross-section of tissue having a certain thickness. In some instances, the imaging device can compact the image data, and/or treat the image data as 2D data, such that there is no perceived thickness. In certain embodiments, when the image slice is displayed in a 3D view, the system can treat the image slice as a 2D or quasi 2D object. In such embodiments, the system can cause the image slice to have little to no perceptible thickness. Accordingly, in certain embodiments, when the image slice is oriented orthogonally or perpendicularly with respect to the point-of-view location, the system can cause the display to display nothing or a line having a relatively small thickness, such as a few pixels, etc. In some cases, the number of pixels used to display the relatively small thickness of the image slice can correspond to the size of the display. For example, more pixels can be used for a larger display and fewer pixels can be used for a smaller display, etc.
Other embodiments can track and display other types of instruments and their features. For example, a healthcare provider may want to track one or more of a scalpel, a biopsy, a cauterizer (including an electrocauterizer and Bovies), forceps, cutting loops on hysteroscopes, harmonic sheers, lasers (including CO2 lasers), etc. For example, in various embodiments, the following devices can be tracked and various aspects of their design displayed on display 220: Olympus™ OES Pro Hystero-Resectoscope, SonoSurg Ultrasonic Surgical System Olympus™ GF-UC 160 Endoscope Wallus™ Embryo Transfer Catheter AngioDynamics® NanoKnife™, VenaCure™ laser, StarBurst, Uniblade, Habib® Resector Bovie™ Electrodes, Covidien Evident™, Cool-tip™ Ablation Antennas, Opti4™ Electrodes Microsulis MEA (microwave endometrial ablation), Acculis Halt™ Medical System Optimed BigLumen Aspiration Catheter Optimed Optipure Stent Central venous catheterization introducer medical device (such as those made by Bard and Arrow).
Once tracked, a healthcare provider is able to see image guidance data on display 220 that will allow her to know the relative pose, location, or emplacement of the tracked instrument(s) with respect to one another or with respect to imaging data and will be able to see, on display 220, the features of the instrument rendered in the scene.
Depicting Medical Device Placement, Trajectory, and Other Image Guidance Cues
In certain procedures, the system can provide image prediction information related to the surgical instruments as image guidance cues. In the context of scalpel movement, this can be the location that the scalpel will hit if a healthcare provider continues to move the scalpel in a particular direction. In the context of ablation or biopsies, this can be the projected medical device placement if it is driven along its central axis, which is also referred to herein as a longitudinal axis.
In some embodiments, to implement the trajectory indicators 208, the image guidance system can draw a number of rings about the axis of the medical device shaft, extrapolated beyond its tip, as depicted in
The rings can, in some embodiments, be spaced at regular (e.g., 0.5, 1, or 2 cm) intervals to provide the healthcare provider with visual or guidance cues regarding the distance from the medical device tip to the targeted anatomy. In some embodiments, the spacing of the rings can indicate other aspects of the data, such as the drive speed of the medical device, the density of the tissue, the distance to a landmark, such as the ultrasound data, or any other appropriate guidance data or property. In some embodiments, the rings or other trajectory indicators can extend beyond the medical device tip, by a distance equal to the length of the medical device-shaft. This way, the user knows if the medical device is long enough to reach the target—even before the tip enters the patient. That is, in some embodiments, if the rings do not reach the target with the tip still outside the body, then the tip will not reach the target even when the entire length shaft is inserted into the body.
Other display markers can be used to show trajectory, such as a dashed, dotted, or solid line, transparent medical device shaft, point cloud, wire frame, etc. In some embodiments, three-dimensional rings can be used and provide depth cues and obscure little of the ultrasound image. Virtual rings or other virtual markers can be displayed semi-transparently, so that they obscure less of the ultrasound image than an opaque marker would.
Other prediction information can also be displayed as image guidance cues. For example, if a scalpel is being tracked by the image guidance system, then a cutting plane corresponding to the scalpel can be displayed (not pictured). Such a cutting plane can be coplanar with the blade of the scalpel and can project from the blade of the scalpel. For example, the projected cutting plane can show where the scalpel would cut if the doctor were to advance the scalpel. Similar prediction information can be estimable or determinable for cauterizers, lasers, and numerous other surgical instruments.
Furthermore, the data from two or more devices can be combined and displayed based on their relative emplacements or poses. For example, the rendered ultrasound image 204 can be displayed on the image plane (e.g., in the image region) with respect to the virtual medical device 202 on the display 220 in a manner that estimates the relative emplacements or poses of the medical imaging device 222 and the medical device 242. As illustrated in
In addition, the display 220 can include another image guidance cue in the form of an intersection indicator 210 that indicates where the virtual ablation medical device 202 (and/or its axis and/or its trajectory) intersects the ultrasound image 204. In some embodiments, the intersection indicator 210 can be displayed before the medical device is inserted, thereby allowing the healthcare provider to see where the medical device will intersect the image, or imaged region. As will be described in greater detail below, in some cases, due to uncertainties related to the emplacement of the medical devices, the system can use a variance parameter to determine and display the intersection indicator 210.
In the illustrated embodiment, a tumor 212 appears in the ultrasound image, or rendered ultrasound image 204, and the virtual ablation needle 202 is shown driven through the tumor 212. As described in greater detail in U.S. application Ser. No. 14/872,930 (the '930 Application), incorporated herein by reference in its entirety, the displayed affected region (or affected region indicator) 206 can indicate what region or volume would be affected when the medical device 242 is operated. In the illustrated embodiment, the displayed affected region 206 can estimate where ablation would occur if the tissue were ablated at that time. As can be seen, in the illustrated embodiment, the displayed affected region 206 appears to cover the tumor displayed in the ultrasound image.
It will be understood that the various embodiments described herein for using a variance parameter associated with a device tracker to determine and display an intersection indicator can also be used to determine and display the displayed affected region 206. Furthermore, the variance parameters described herein can be used alone or in combination with the various variance parameters described in the '930 Application to determine and display the affected regions described therein, including the surface display regions.
Various embodiments can include any combinations of the graphics described above and/or other graphics or image guidance cues. For example, in some embodiments, data related to a single surgical instrument (such as an ablation needle, ultrasound probe, etc.) can be presented in more than one manner on a single display. Consider an embodiment in which device 242 is an ablation needle and device 222 is an ultrasound transducer. As mentioned previously, as the medical devices are displayed in a virtual 3D space, with the screen 220 acting as a window into the virtual 3D space, if a healthcare provider orients medical imaging device 222 such that it is perpendicular to the point-of-view or point-of-view location (e.g., perpendicular to the screen), the perspective view of the ultrasound image 204 would show only the edge and the contents of the ultrasound image 204 would not be visible. In some embodiments, the image guidance system can track the healthcare provider's head using an emplacement sensor and/or a position sensing unit. In some embodiments, such as, when the head of a user is tracked, the healthcare provider can then move her head to the side, so that she sees the ultrasound image from a different point of view location.
In some embodiments, the image guidance system can concurrently display an additional 2D view 205 of the ultrasound image, simultaneous to the 3D depiction 204, so that the ultrasound image is always visible, regardless of the emplacement in which the healthcare provider holds the medical imaging device 222. The 2D view 205 of the ultrasound data can be similar to what a healthcare provider is accustomed to seeing with traditional ultrasound displays. This can be useful to provide the healthcare provider with imaging to which she is accustomed and allows a healthcare provider to see the ultrasound data regardless of the then-current emplacement of the ultrasound probe with respect to the user.
In some embodiments, the 2D view 205 of an ultrasound image is depicted in the upper right corner of the monitor (though it can be placed in any location). In some embodiments, the guidance system can automatically (and continually) choose a corner in which to render the 2D view 205 of the ultrasound image, based on the 3D position of the surgical instruments in the rendered scene. For example, in
In some embodiments, the system 101 attempts to avoid having the 2D view 205 of the ultrasound image quickly moving among corners of the display in order to avoid overlapping with graphics and data in the display. For example, a function f can be used to determine which corner is most suitable for the 2D ultrasound image to be drawn in. The inputs to f can include the locations, in the screen coordinate system, of the displayed medical device tip, the corners of the 3D view of the ultrasound image, etc. In some embodiments, f s output for any given point in time is independent of f's output in the previous frames, which can cause the ultrasound image to move among corners of the display rapidly. In some embodiments, the image guidance system will filter f's output over time. For example, the output of a filter g, for any given frame, could be the corner, which has been output by f the most number of times over the last n frames, possibly weighting the most recent values for f most heavily. The output of the filter g can be used to determine in which corner of display 220 to display the 2D ultrasound image and the temporal filtering provided by g can allow the 2D view 205 of the ultrasound image display to move more smoothly among the corners of the display 220.
In some embodiments, other appropriate virtual information and/or image guidance cues can be overlaid on the 2D view 205 of the ultrasound image as well as the 3D view 204. Examples include: orientation indicator 214, an indication of the distance between the medical device's tip and the point in the plane of the ultrasound image that is closest to the medical device tip; the cross section or outline of the ablation volume that intersects with the ultrasound slice; and/or the intersection point, box, outline, etc. between the virtual medical device's axis and the ultrasound image plane.
Furthermore, it will be understood that other image guidance cues can be generated and displayed on the display as described in greater detail in the '274 Application, previously incorporated herein by reference. For example, the system 101 can generate and/or display graphical indicators that help indicate the spatial relationship between a medical device and an ultrasound image plane (e.g., graphical image plane indicators) or other plane indicators to indicate the relative positions of the virtual medical device(s) and ultrasound image, features of interest, annotations, foundational plane indicators, foundational plane intersection indicators, other graphical indicators, approximate medical device location indicators, etc. As described in greater detail above and in the '274 Application, the various image guidance cues can be generated based at least in part on the emplacement information of the medical devices used with the system 101.
Figures Overview
Furthermore, it will be understood that any one or any combination of the display objects shown in the figures can be displayed alone or in combination with any one or any combination of the display objects shown in other figures. For example, in some embodiments, only an intersection indicator or variance volume indicator is displayed on the screen 220. In certain embodiments, only an intersection indicator and at least one of the virtual medical imaging device or virtual medical device are displayed on the screen 220, etc.
Emplacement Variance
In some cases, there can be some uncertainty as to the precise emplacement of the tracked medical device 242. For example, a device tracker associated with the medical device can have some error or variance associated with it (e.g., 5%-10%). The variance may be due to noise, jitter, vibration, manufacturing and/or mechanical tolerances involved when affixing the pose sensor to the medical devices. The variance may result in the precise emplacement of the medical device being different than the emplacement of the virtual medical device displayed on the screen 220.
In some cases, the operating parameters of a device tracker can include one or more emplacement variance parameters indicating the amount of variance that a healthcare provider can expect when using a particular device tracker. The emplacement variance parameter may indicate a percentage certainty of the location of the device tracker (non-limiting examples: 95% or 99%) and/or may indicate that a device tracker operates within a certain range, or that a healthcare provider can expect a certain variance in location, such as a particular standard deviation and/or +/− some percent. For example, the emplacement variance parameter may indicate that the location of the device tracker is in a particular location with an error of one or more millimeters or 5%-10%, etc.
In some embodiments, the system can account for some uncertainty about the spatial relationship between the virtual medical device and the image plane/region using the variance parameter. For example, in some embodiments, the system models, the medical device, not as just a one-dimensional axis, but as a three dimensional tube, with a diameter that is related to the accuracy of the tracking system (accuracy can be based on measurement error, noise, jitter, vibration, due attributable to the user and/or attributable to the pose sensor). Similarly, in certain embodiments, the system can model the image plane/region as a three-dimensional slab, with a thickness that is related to the accuracy of the system. The system can use the uncertainty to generate and display to the user graphic indicators (analogous to error-bars on a scientific plot), such as a variance volume indicator, intersection indicator, etc.
It will be understood that any one or any combination of the display objects shown in
To determine and display the virtual medical imaging device 302, the system 101 can use emplacement data associated with a medical imaging device that corresponds to the virtual medical imaging device 302 and/or dimensions of the medical imaging device. The system 101 can use the dimensions to determine the shape and dimensions of the virtual medical imaging device 302 and/or can use the emplacement data to determine the emplacement of the virtual medical imaging device 302. Using the emplacement data associated with the medical device that corresponds to the virtual medical device 306 and/or dimensions of the medical imaging device, the system 101 can determine and display the virtual medical device 306.
Similarly, the system 101 can use the emplacement data associated with the medical imaging device and/or its operating parameters to determine and display the image region 304. For example, the system 101 can use the operating parameters (e.g., height, length, width) to determine, the shape and dimensions of the image region and/or can use the emplacement data to determine the emplacement of the image region 304. In addition, as imaging data is received from the medical imaging device, the system 101 can combine the imaging data with the image region 304, as illustrated in
Image width indicators 312a, 312b and image slab 314 are shown in
As mentioned above, medical imaging devices often capture a cross-section of tissue having a certain thickness. However, in some instances, a medical imaging device treats the captured cross-section as if there is no thickness and compacts the image data so that there is no perceived thickness in the image data. The image width indicators 312a, 312b and/or image slab 314 can be used to illustrate a width of the imaged region that corresponds to the image data that is shown in the image region 304, prior to the image data being compressed. In addition, the image width indicators 312a, 312b and/or image slab 314 can be used to determine one or more intersection indicators as described in greater detail below with reference to
To determine the variance volume, the system 101 can use a determined axis of the virtual medical device 306 and the variance parameters. For example, the system 101 can calculate a volume surrounding the axis based at least in part on the variance parameter. Once determined, the system 101 can cause a variance volume indicator 310 to be displayed on the screen 220.
In some embodiments, to display the variance volume indicator 310, the system 101 can determine the emplacement of the virtual medical device based at least in part on the emplacement data associated with a medical device and display variance volume indicator based at least in part on the determined emplacement of the virtual medical device. In some cases determining the emplacement of the virtual medical device can include receiving x, y, z and/or quaternion orientation coordinates associated with a device tracker that is associated with the medical device and mapping the received coordinates to display coordinates associated with the screen 220. Once the emplacement of the virtual medical device is determined, the system 101 can determine the variance volume as a volume surrounding the medical device and/or the axis of the medical device. To display the variance volume indicator 310 (and/or any display object described herein), the system 101 can communicate the coordinates of the variance volume (and/or any display object described herein) to a graphics rendering engine, which can convert the emplacement data to display coordinates and communicate the resulting rasterized image to a display buffer, which is then converted to a video signal (e.g. DVI/HDMI) and sent to a display screen 220.
In the illustrated embodiment, the variance volume indicator 310 is displayed using multiple, equally-spaced rings surrounding and along the axis of the virtual medical, as well as two lines illustrating the perimeter of the variance volume. In this way, the variance volume indicator 310 appears to be made up of multiple cylinders stacked on top of one another. However, it will be understood that the variance volume indicator 310 can be displayed in a variety of ways, as desired. For example, the rings may not be equally-spaced or not included at all. Similarly, the perimeter lines may be omitted. In some embodiments, the variance volume indicator 310 can be displayed as a long tube along the axis of the virtual medical device. The tube can be shaded or textured as desired.
The variance volume can also be drawn as animated bars that rotate about the center of the medical device axis. In some embodiments, the longitudinal axis of the bars can be parallel to the longitudinal axis of the medical device. In certain embodiments, the longitudinal axis of the bars can be at an angle with respect to the longitudinal axis of the medical device (e.g., perpendicular, forty-five degrees, or any other angle). Each bar can be a predetermined length that spans the entire medical device or just a portion thereof. Furthermore, there can be multiple sets of rotating bars at different locations along the medical device. Each set of rotating bars along the axis can include one or more bars. For example, in some embodiments, there can be three sets (each set located at a different position along the medical device) of three bars each. It will be understood that any number of sets of bars can be used and that each set can include any number of bars.
In some embodiments, the variance parameter can be fixed such that the variance volume does not change. In certain embodiments, the variance parameter may change over time. In such embodiments, the variance volume and the variance volume indicator can change over time as well. In some embodiments, the variance parameter may not be uniform for the length of the needle. In such embodiments, the variance volume indicator 110 can indicate the different variance parameters along the medical device. Furthermore, although the variance parameter has been described with respect to the virtual medical device 306, it will be understood that a variance parameter associated with the virtual medical device 302 can be used alone or in combination with the variance parameter associated with the virtual medical device 306. The variance parameter associated with the virtual medical device 302 can be used to determine the emplacement of the virtual medical device 302 and medical device associated therewith and to display a variance volume associated with the virtual medical device 302. Accordingly, more than one variance parameter can be used by the system 101 to determine emplacement of the virtual medical devices 302, 206 and display them on the screen 220.
At block 402, the system 101 receives emplacement data associated with a medical device. In some embodiments, the emplacement data can be received from a device tracker associated with the medical device and/or a position sensing unit 106. In certain embodiments, the emplacement data includes emplacement coordinates, such as, but not limited to one or more x, y, z position coordinates and/or quaternion orientation coordinates.
At block 404, the system 101 determines emplacement of a virtual medical device associated with the medical device. In some embodiments, the system 101 uses the emplacement data associated with the medical device to determine the emplacement of the virtual medical device. In certain embodiments, the system 101 determines the emplacement by converting the emplacement coordinates corresponding to a coordinate system of the position sensing unit 106 to a coordinate system corresponding to a display. In some embodiments, the system 101 can use dimensions of the medical device (e.g., length, circumference, etc.) to determine the emplacement of the virtual medical device. The system 101 can include a non-transitory computer-readable medium that stores the dimensions of various medical devices that can be used with the system and/or receive the dimensions from the medical device or elsewhere dynamically.
At block 406, the system 101 can determine a variance volume based at least in part on one or more operating parameters associated with the device tracker that is associated with the medical device. In some embodiments, the operating parameters can include a location variance parameter. In some embodiments, the system 101 can use a determined axis of the virtual medical device and the variance parameter to determine the variance volume. In certain embodiments, the system 101 can use the trajectory of the virtual medical device and/or the dimensions of the virtual medical device to determine the variance volume.
At block 408, the system 101 can cause one or more displays to display a variance volume indicator or at least a portion of the variance volume, as described in greater detail above. In some embodiments, the variance volume indicator can correspond to at least a portion of the variance volume that intersects with an image region, as will be described in greater detail below with reference to
In some embodiments, to cause the one or more displays to display the variance volume indicator (and/or any of the display objects described herein), the system 101 can communicate the emplacement data of the variance volume (and/or display object) to graphics rendering engine, which can convert the emplacement data to display coordinates and communicate the resulting rasterized image to a display buffer, which is then converted to a video signal (e.g. DVI/HDMI) and sent to a display screen 220.
It will be understood that fewer, more, or different blocks can be used as part of the routine 400. For example, in some embodiments, the system 101 can cause the one or more displays to display the virtual medical device as illustrated at block 410 and described in greater detail above. Furthermore, the blocks of routine 400 can be combined with any one or more of the blocks described below with reference to
Intersection Indicator
The emplacement variance can also affect the certainty with regard to the emplacement of an intersection between the imaged region and the medical device.
To determine the intersection indicator 510, the system 101 can use the emplacement data associated with the medical device and the medical imaging device. The system can determine the intersection in the display coordinate system and/or the coordinate system of the position sensing unit 106. For example, the system 101 can determine an intersection of the trajectory and/or axis of the medical device and the image plane/region and/or the imaged region and/or an intersection of the trajectory and/or axis of the virtual medical device with the image plane/region. In addition, the system can determine the intersection of an axis associated with the first emplacement data, or first emplacement data axis, and a plane associated with the second emplacement data, or second emplacement data plane. For simplicity, reference is made to determining an intersection of the image plane/region and the virtual medical device 302, however, it will be understood that other methods can be used to determine an intersection of the image plane/region or imaged region and an axis of the medical device.
In some embodiments, to determine the intersection, the system 101 can compare the various coordinates of the two objects (e.g., axis/trajectory and region/plane). If a pair of coordinates (e.g., the x, y, z coordinates from each object) match (e.g., are equal) or satisfy a distance threshold, the system can determine that the two objects intersect. In certain embodiments, the system 101 can determine that there is an intersection if the trajectory/axis of the virtual medical device 302 and a portion of the image plane/region can be mapped to the same pixels in a video or image output data buffer.
The distance threshold can be a predefined distance, such as one or more bits, one or more pixels, etc. In some embodiments, the distance threshold can be based at least in part on whether the distance between the coordinates is perceptible to a user, which may be based at least in part on the size of the display, the size of the display relative to the image and/or imaged region, and/or the distance between the point-of-view location and the display, etc. For example, in some cases, the distance threshold can be smaller for larger displays (or larger display:image ratios) and larger for smaller displays (or smaller display:image ratios), or vice versa. In certain cases, the distance threshold can be larger for larger distances between the point-of-view location and the display and smaller for smaller distances between the point-of-view location and the display, or vice versa. In certain embodiments, the distance threshold can be different for each coordinate.
In certain embodiments, the system 101 can perform the comparison for each location along the axis of the virtual medical device and/or image plane/region. In some cases, the system can determine that there is an intersection if the axis/trajectory of the virtual medical device and a portion of the image plane/region are level and have the same depth.
As mentioned above, any coordinate system can be used to compare the coordinates of the virtual medical device with the image plane/region and/or to determine whether the virtual medical device and the image plane/region intersect. For example, the coordinate system of the display and/or the coordinate system of position sensing unit 106 can be used as desired.
In some embodiments, for each location on the display, the system can query whether a portion of the two display objects have been (or will be) mapped to that location. If the system 101 determines that a portion of two display objects (e.g., the trajectory of the virtual medical device and the image region have been (or will be) mapped to that location, the system 101 can determine that the two display objects intersect. In certain embodiments, the system 101 can determine that the two display objects satisfy the location threshold and/or intersect if the two objects map to the same location on a display, such as the same pixel or same array of pixels.
In some embodiments, the system 101 can determine the intersection indicator based at least in part on the determined intersection of the axis of the virtual medical device and the image region and a variance parameter associated with the device tracker associated with the virtual medical device. For example, once the intersection is determined, the system 101 can use the variance parameter to generate an area on the image region 304 that represents the potential location of intersection. In some cases, the center of the area can correspond to the determined point of intersection.
In some embodiments, the system 101 can determine and/or display the 3D shape that results from the intersection of the slab containing the image plane (e.g., the volume between the image width indicators 312a, 312b), and the variance volume containing the medical device axis (illustrated as a cylinder surrounding the medical device and its trajectory, with multiple circles at regular (or irregular) intervals). This can be drawn, transparently composited, with the image and medical device or medical device trajectory.
In certain embodiments, the system 101 can use the intersection of a determined variance volume with the image plane/region to determine the intersection indicator. For example, the area or perimeter of the variance volume that intersects with the image plane/region can be used as the intersection indicator. Such an embodiment is illustrated in
Orientation Angle
In some embodiments, the system 101 can use an orientation angle or angle-of-approach to determine and display the intersection indicator 510. The orientation angle or angle-of-approach can correspond to the angle between the image plane and the medical device axis and/or the virtual medical device axis.
As the angle-of-approach decreases (e.g., the medical device is moved closer to being parallel with the image plane), the potential point(s) of intersection increase. Accordingly, in some embodiments, the system 101 can use the angle-of-approach to determine and display the intersection indicator. In certain embodiments, when the orientation angle satisfies a threshold angle, the intersection indicator can be deactivated.
In some embodiments, the system 101 can generate a 3D intersection shape described above and/or generate an intersection shape based on the intersection of the variance volume and the image plane/region, project it onto the image plane, and draw its outline on the image plane. For example, if the medical device (or virtual medical device) axis is at a 90-degree angle-of-approach to the image plane, the system can draw a hollow circle. As illustrated in
Additionally, when the angle-of-approach becomes zero (or approximately zero), the major axis becomes infinite, and the intersection indicator can become two parallel lines, which can be unbounded. A non-limiting example is shown in
In some embodiments, the system 101 can compare the orientation of the axis of the medical device or virtual medical device with the orientation of the image plane/region. Based on the comparison, the system 101 can increase or decrease the size of the intersection indicator. In some embodiments, as the angle between the orientations decreases (moves towards parallel), the size of the intersection indicator can increase. In certain embodiments, when the angle between the orientations is equal or approximately equal, the intersection indicator can be displayed as two parallel lines, which can be unbounded parallel lines.
Obround Intersection Indicator
In some embodiments, the system can use the intersection of the axis of the virtual medical device with multiple planes of the image region or image slab to determine and display the intersection indicator.
The intersection indicator 710 can be determined in a variety of ways using the image region/slab 314. In some embodiments, the intersection shape can be based on the intersection of the variance volume across the image region or slab 314 and in certain embodiments, the intersection shape can be determined based on the intersection of the variance volume with one or more planes within the image region/slab 314.
For example, in some cases, the intersection indicator 710 can be based at least in part on the intersection of the variance volume with the image width indicator 312a (displayed as intersection indicator 712a), with the image width indicator and 312b (displayed as intersection indicator 712b), and with the image region 304 (displayed as intersection indicator 712c). Combining or projecting the three intersection indicators 712a, 712b, 712c onto the image region 304 can result in the intersection indicator 710 displayed on image region 304. In some cases, as part of the projecting, the rounded portions of the indicators 712a, 712b, 712c between the distal rounded portions can be removed.
In some embodiments, the intersection indicator 710 can be based on only the intersection indicators 712a and 712b and/or can omit determining the intersection of the variance volume with the image plane 304. In such embodiments, when the intersection indicators 712a and 712b are projected onto the image region 304, lines can be drawn between the distal rounded edges to generate the intersection indicator 710. As mentioned above, in some cases, as part of the projecting, the rounded portions of the indicators 712a, 712b between the distal rounded portions can be removed.
Device-Blocking-Objects
Based on emplacement data associated with these device-blocking-objects, the system can display corresponding display objects in their proper spatial arrangement with the image plane and the virtual medical device. The emplacement data can be received from device trackers, position sensing units 106, and/or based on 3D image data, such as a registered CT, MRI, etc. Using the emplacement data associated the device-blocking-objects and the medical device, the system 101 can determine any intersections. Based on the determined intersections, the system 101 can project the intersection indicator onto the surfaces of the device-blocking-blocking display objects. In some embodiments, the system 101 can determine which objects are device-blocking-objects by determining that an object intersects with the axis or variation volume of the medical device and the intersection is located between the medical device and an intersection of the medical device and the image region.
In addition, portions of the intersection indicator on the image plane that are blocked by a device-blocking object can be a different color, grayed out, or not drawn. For example, portions of the intersection indicator 810a that are blocks by the blood vessel 802 are displayed differently than portions of the intersection indicator 810a that are not blocked by the blood vessel 802. In this way, the system 101 can convey to a user that the device will not reach the target seen in the image region (if the medical device trajectory is not changed), which device-blocking-objects are in the way, which portions of them are in the path of the medical device, and if the medical device trajectory is barely or nearly blocked (since the intersection indicator has some width, diameter related to the accuracy of the system).
With respect to
Similar to
The rectilinear display objects 910a, 910b can be determined similar to the determination of the intersection indicators described above with reference to
Image Region and Medical Device Image Difference
In some embodiments, the medical image to be displayed on the image region may not match the size and/or shape of the image region 304, as illustrated in
In some embodiments, the system 101 can compare the dimensions of the medical image 1002 with the dimensions of the image region 304. In certain embodiments, the dimensions can be stored in a non-transitory computer-readable medium associated with the system 101 and/or can be received from the medical imaging device, etc. Upon determining that the compared dimensions are different, the system 101 can identify the portions of the image region 304 that are outside, or do not overlap with, the medical image 1002. When displaying the image region 304 and the medical image 1002, the system 101 can display the portions of the image region 304 that overlap with the medical image 1002 with the medical image 1002 and can display the portions of the image region 304 outside, or that do not overlap with, the medical image 1002 differently to highlight the difference from the medical image 1002.
Off-Image Region Intersection
The visual elements can include, as non-limiting examples, any one or any combination of changing the border of the image region 304 to be thicker 1102, and/or a different color (e.g. add a thick red border); altering the display of the image region 304 (increasing brightness, contrast); altering the display of the entire scene (e.g., displaying a border around the scene or changing the background of the display objects, etc; displaying a warning sign; displaying an arrow 1104 indicating in which direction the intersection indicator 1110 lies (e.g., the arrow 1104 may be overlaid/superimposed onto the image region 304, or drawn just beyond the border of the image region 304); displaying the numerical distance between the intersection indicator and the image region 304 (e.g., measured from the center of the image region 304, from a border of the image region 304, or other location); and/or displaying one or more lines connecting the intersection indicator to a portion of the image region's border (line 1106) or to the center of the image region 304 (line 1108), to visually indicate the intersection-indicator's location to the user, as also described in U.S. application Ser. No. 12/703,118, incorporated herein in its entirety.
The connecting lines 1106, 1108 can, in some embodiments, include a distance indicator, such as a numerical display, or ruler tick marks. In some cases, the distance indicator can be superimposed on the connecting lines 1106, 1108, to show how far the intersection indicator 1110 is from the image region 304, and to show if it is moving toward or away from the image region 304. In some embodiments, the ruler's 0-mark can be anchored at the center of the intersection indicator 1110. In this way, even if the intersection indicator 1110 is off-screen, the user can see if it is moving closer to the image region 304 (which can be visible on-screen) because the ruler tick marks will appear to scroll toward the image region. Similarly, if the intersection-indicator is moving farther away from the image region 304, the tick marks can appear to scroll away from the image region 304.
In some embodiments the connecting line 1108 can connect to the center point (or some other point) of the intersection indicator 1110. However, when the medical device is almost parallel to the image plane (i.e. the angle between medical device and the image plane approaches zero degrees), the intersection indictor 1110 can fluctuate significantly. Accordingly, in certain embodiments, the connecting line 1108 can be constructed as follows: line 1106 can be determined from the center of the image region 304 to the point on the intersection indicator 1110 that is closest to the center of the image region 304. Where line 1106 intersects the edge of the image region 304, the connecting line 1108 can begin, and can continue until it reaches the intersection indicator 1110. In certain embodiments, the connecting line 1108 can be aligned such that it is perpendicular to the closest edge of the image region 304.
In some embodiments, the system can determine the emplacement of the medical device and the image region. In addition, the system can determine an axis and/or variance volume associated with the medical device does not intersect with the image plane within the image region and/or does not intersect with the image plane within the boundaries of the display screen. Based at least in part on this determination, the system can determine and display one or more visual indicators indicating that the axis/variance volume does not intersect with the image region 304, as described in greater detail above. In some cases in which the system 101 determines that the axis/variance volume intersects with the image plane outside the image region but within the display screen, the system 101 can display the intersection indicator 1110 outside the image region 304.
As described previously, the system can use an internal model for the length of the needle to determine whether the needle can reach a particular location inside the patient. For example, trajectory rings, similar to those described in greater detail in U.S. application Ser. No. 12/703,118, can extend forward of the tip, and be projected some distance forward of the tip, such as the needle length (distance from needle tip to needle handle), to allow the clinician to see when the needle is not long enough to reach the target. In certain embodiments, the system can display the intersection indicator in a different style (e.g. change the color, line width, symbol, line dashes, etc.) when distance from the intersection indicator to the medical device tip is greater than the length of the needle. This allows the user to know where the needle is aimed, but also determine that the needle cannot reach a particular location. Accordingly, in some embodiments, the system can determine a trajectory of the medical device and cause one or more displays to display trajectory indicators based at least in part on the length of the medical device.
At block 1202, the system receives first emplacement data associated with a first medical device. At block 1204, the system receives second emplacement data associated with a second medical device. In certain embodiments, one of the medical devices can be a medical imaging device, as discussed in greater detail above. Furthermore, as mentioned above, the emplacement data associated with each medical device can be received from one or more device trackers associated with the respective medical device and/or from a position sensing unit that tracks the device trackers. In some embodiments, the emplacement data can include 3D coordinates and/or quaternion orientation coordinates.
At block 1206, the system determines an emplacement of a first virtual medical device corresponding to the first medical device based at least in part on the first emplacement data. In some embodiments, to determine the emplacement of the first virtual medical device, the system can map or transform the received emplacement data to a coordinate system associated with a virtual 3D space and/or the display screen. Furthermore, the system can use the characteristics (e.g., length, width, shape, location of tip, angle, location of the device tracker on the medical device, etc.) of the medical device to determine the emplacement of the virtual medical device. In some embodiments, the system can use a CAD file, 3D model, or other file to determine the characteristics of the medical device and to determine its emplacement.
In some embodiments, the virtual 3D space coordinate system and/or the display screen coordinate system can be based at least in part on a point-of-view location. Thus, the emplacement of the first virtual medical device (and other display objects) can be with respect to a point-of-view location). The point-of-view location can be a fixed location with respect to the display screen and/or can be a dynamic location. In some embodiments, when the point-of-view location is a fixed location it can correspond to a location that does not change during a medical procedure. For example, the fixed location can correspond to an expected location of a medical practitioner (e.g., presume that the medical practitioner will be 10 ft. in front of the display screen). In certain embodiments, the dynamic location can correspond to a location that can change during a medical procedure. For example, the system can track a medical practitioner during a medical procedure (e.g., by affixing a device tracker on the medical practitioner's head) and adjust the point-of-view location based at least in part on a real-time determination of the location of the medical practitioner.
At block 1208, the system determines an emplacement of a second virtual medical device corresponding to the second medical device based at least in part on the second emplacement data. The emplacement of the second virtual medical device can be determined in similar fashion to the emplacement of the first virtual medical device. For example, the system can map or transform the emplacement data to a coordinate system associated with the virtual 3D space and/or the display screen. In addition, the system can use the characteristics of the second medical device to determine its emplacement.
At block 1210, the system determines an emplacement of an image region based at least in part on the second emplacement data. In some embodiments, the system can use the characteristics of the second medical device to determine the location of the image region associated with the second medical device. For example, the characteristics may indicate a location of an imager on the medical device, as well as the specification of the image that is generated using the imager (e.g., height, width, and/or depth). Using this information, the system can determine the emplacement of the image region associated with the second medical device. Furthermore, the system can determine the emplacement of the image region directly from the second emplacement data and/or from the determined emplacement of the second virtual medical device. For example, the system can use a known relationship between the second emplacement data and the location of the image region (e.g., the image region begins 2 in. away from the of the second emplacement data location in a particular direction and ends 5 in. away) and/or use a known relationship between the emplacement of the second virtual medical device and the location of the image region (e.g., the image region begins 4 inches from the tip of the virtual medical device and ends at the tip of the virtual medical device).
At block 1212, the system determines an intersection. In certain cases, the intersection can correspond to an intersection of an axis associated with the first emplacement data and any display object (e.g., virtual medical device, image plane/region, other medical image data (e.g., CT scan, MM scan data), etc.). In some cases, the intersection can correspond to an intersection of an axis associated with the first emplacement data, or first emplacement data axis, and a plane associated with the second emplacement data, or second emplacement data plane. In some embodiments, the first emplacement data axis corresponds to an axis of the first medical device and/or the first virtual medical device and the second emplacement data plane corresponds to a plane associated with the second medical device and/or the second virtual medical device.
As mentioned above, using the first emplacement data, the system can determine a trajectory and/or axis associated with the first medical device (e.g., the first emplacement data axis). Similarly, the system can determine a plane associated with the second medical device using the second emplacement data (e.g., second emplacement data plane, image plane/region). In some embodiments, the determined plane can be parallel with a longitudinal axis of the second medical device and/or the second emplacement data plane. Using the first emplacement data axis and the second emplacement data plane, the system can determine an intersection. In some embodiments, the system can determine an intersection based at least in part on a determination that two objects are co-located as described in greater detail above.
At block 1214, the system determines an intersection indicator based at least in part on the determined intersection, a variance parameter associated with a device tracker that is associated with the first medical device, and/or an angle-of-approach. As mentioned above, in some embodiments, the first and/or second emplacement data can include some inaccuracy. Accordingly, the system can determine an intersection indicator taking into account the inaccuracy by using one or more variance parameters that are associated with the inaccuracy and/or the angle-of-approach.
In some embodiments, the system can determine the intersection indicator using an angle-of-approach, which can correspond to an angle difference between the first emplacement data axis and the second emplacement data plane (e.g., angle between the trajectory of the first medical device and the image plane/region). In certain embodiments, the size of the intersection indicator varies in proportion to the angle-of-approach. For example, as the angle-of-approach decreases, the size of the intersection indicator can increase.
In certain embodiments, the system can use an intersection of a variance volume associated with the first medical device (and/or the first emplacement data axis) with the image plane/region (and/or second emplacement data plane or axis) to determine the intersection indicator. For example, the intersection indicator can correspond to an area of intersection, the outline of the intersection on the image/plane/region, and/or the projection onto the image region of the intersections of the variance volume with portions of the image region. In some cases, the system can use an intersection of the variance volume associated with the first medical device with image width indicators (or any portions of the image region) to determine the intersection indicator. In some embodiments, the system can determine the intersection of the first emplacement data axis with the second emplacement data plane and generate an intersection indicator by determining an area or perimeter around the determined intersection. The area/perimeter can be determined using the variance parameter and/or the angle-of-approach.
At block 1216, the system causes one or more displays to concurrently display a perspective view of the first virtual medical device based at least in part on the determined emplacement of the first virtual medical device, a perspective view of the second virtual medical device based at least in part on the determined emplacement of the second virtual medical device, a perspective view of the image region based at least in part on the determined emplacement of the image region, and the intersection indicator. It will be understood that the system 101 can map any images received from the second medical device and/or image data corresponding to the determined emplacement of the second medical device to the image region and/or display the mapped data as part of the image region.
As mentioned above, the display screen coordinate system can correspond to a point-of-view location and the various display objects (virtual medical devices, image region, intersection indicator, and other guidance cues) and their emplacements can be determined with respect to the point-of-view location. Accordingly, the system can cause one or more displays to display the perspective view of the display objects.
It will be understood that fewer, more, or different blocks can be used as part of the routine 1200. For example, the routine 1200 can include blocks for determining and displaying intersection indicators on one or more display objects other than the image region and/or a shaded region, as described in greater detail below with reference to
At block 1302, the system determines an emplacement of a first virtual medical device associated with a first medical device based at least in part on first emplacement data. As described above, the first emplacement data can correspond to a device tracker associated with a first medical device that corresponds to the first virtual medical device, and the first emplacement data can be received from the first device tracker and/or a position sensing unit.
At block 1304, the system determines an emplacement of an image region based at least in part on second emplacement data associated with a second medical device. As described above, the image region can be determined directly from the second emplacement data and/or using emplacement of a second medical device (or virtual medical device) that is associated with the image region.
At block 1306, the system determines an intersection based at least in part on the first emplacement data and the second emplacement data. As described om greater detail above, the intersection can correspond to an intersection between a first emplacement data axis and a second emplacement data plane, a variance volume/trajectory/axis and an image plane/region (or portions thereof), etc. In some embodiments, the intersection can correspond to an intersection between the first emplacement data axis, variance volume, trajectory, or axis with a display object, such as the virtual medical device, pre-operative data (e.g., blood vessel, organ, etc.), etc.
At block 1308, the system determines an intersection indicator based at least in part on the determined intersection. In some embodiments, the intersection indicator is further determined based at least in part on at least one of a variance parameter associated with a device tracker that is associated with the first medical device and/or an angle-of-approach. In certain embodiments, the size of the intersection varies in proportion to the angle-of-approach, as discussed in greater detail above.
At block 1310, the system causes one or more displays to display the intersection indicator. As described in greater detail above, the intersection indicator can be displayed in a perspective view in a virtual 3D space. The perspective view can be based at least in part on a point-of-view location.
It will be understood that fewer, more, or different blocks can be used as part of the routine 1300. For example, in some embodiments, the system 101 can cause the one or more displays to display one or more virtual medical devices, the image region, a medical image, one or more guidance cues, such as a trajectory indicator, etc. In certain embodiments, the routine 1300 can omit block 1308 and display an intersection indicator (block 1310) based on the determined intersection. In some embodiments the trajectory indicator can be based at least in part on the dimensions of the medical device. For example, the trajectory indicator can extend to a location that the medical device can reach based on its length. Furthermore, as non-limiting examples, the routine 1300 can include any one or any combination of blocks 1312, 1314, 1316, and/or 1318.
At block 1312, the system can determine and cause one or more displays to display a variance volume indicator based at least in part on a variance parameter associated with a device tracker that is associated with the first medical device.
At block 1314, the system can determine and cause one or more displays to display a visual indicator that the axis/variance volume does not intersect with the image region based at least in part on a determination that an axis and/or variance volume associated with the first virtual medical device intersects with a location outside the region but within a viewing area, and.
At block 1316, the system can determine and cause one or more displays to display a shaded region on the image region based at least in part on a determination that an axis and/or variance volume associated with the first virtual medical device intersects with a display object between the virtual medical device and an obstructed portion of the image region.
At block 1318, the system can determine and cause one or more displays to display portions of the image region outside a medical image differently than portions of the image region that overlap with the medical image based at least in part on a determination that the size and/or shape of the image region does not correspond to the size and/or shape of the medical image
Those having skill in the art will further appreciate that the various illustrative logical blocks, modules, circuits, and process steps described in connection with the implementations disclosed herein can be implemented as electronic hardware, computer software, or combinations of both. To clearly illustrate this interchangeability of hardware and software, various illustrative components, blocks, modules, circuits, and steps have been described above generally in terms of their functionality. Whether such functionality is implemented as hardware or software depends upon the particular application and design constraints imposed on the overall system. Skilled artisans can implement the described functionality in varying ways for each particular application, but such implementation decisions should not be interpreted as causing a departure from the scope of the present invention. One skilled in the art will recognize that a portion, or a part, can comprise something less than, or equal to, a whole. For example, a portion of a collection of pixels can refer to a sub-collection of those pixels.
The various illustrative logical blocks, modules, and circuits described in connection with the implementations disclosed herein can be implemented or performed with a processor, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA) or other programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof designed to perform the functions described herein. A processor can be a microprocessor, but in the alternative, the processor can be any conventional processor, controller, or microcontroller. A processor can also be implemented as a combination of computing devices, e.g., a combination of a DSP and a microprocessor, a plurality of microprocessors, one or more microprocessors in conjunction with a DSP core, or any other such configuration.
The steps of a method or process described in connection with the implementations disclosed herein can be embodied directly in hardware, in a software module executed by a processor, or in a combination of the two. A software module can include program instructions that instruct a hardware processor, and can be stored in RAM memory, flash memory, ROM memory, EPROM memory, EEPROM memory, registers, hard disk, a removable disk, a CD-ROM, or any other form of non-transitory computer-readable medium known in the art, as computer-executable instructions. An exemplary computer-readable storage medium is coupled to the processor such the processor can read information and/or computer-executable instructions from, and write information to, the computer-readable storage medium. In the alternative, the storage medium can be integral to the processor. The processor and the storage medium can reside in an ASIC or FPGA. The ASIC or FPGA can reside in a user terminal, camera, or other device. In the alternative, the processor and the storage medium can reside as discrete components in a user terminal, camera, or other device.
Headings are included herein for reference and to aid in locating various sections. These headings are not intended to limit the scope of the concepts described with respect thereto. Such concepts can have applicability throughout the entire specification.
Conditional language such as, among others, “can,” “could,” “might” or “may,” unless specifically stated otherwise, are otherwise understood within the context as used in general to convey that certain embodiments include, while other embodiments do not include, certain features, elements and/or steps. Thus, such conditional language is not generally intended to imply that features, elements and/or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without user input or prompting, whether these features, elements and/or steps are included or are to be performed in any particular embodiment.
Language such as the phrase “at least one of X, Y and Z,” and “at least one of X, Y or Z,” unless specifically stated otherwise, is understood with the context as used in general to convey that an item, term, etc. may be either X, Y or Z, or any combination thereof. Thus, such language is not generally intended to imply that certain embodiments require at least one of X, at least one of Y and at least one of Z to each be present or exclusively X or exclusively Y or exclusively Z.
Unless otherwise explicitly stated, articles such as ‘a’ or ‘an’ should generally be interpreted to include one or more described items. Accordingly, phrases such as “a device configured to” are intended to include one or more recited devices. Such one or more recited devices can also be collectively configured to carry out the stated recitations. For example, “a processor configured to carry out recitations A, B and C” can include a first processor configured to carry out recitation A working in conjunction with a second processor configured to carry out recitations B and C.
The previous description of the disclosed implementations is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these implementations will be readily apparent to those skilled in the art, and the generic principles defined herein can be applied to other implementations without departing from the spirit or scope of the invention. Furthermore, although described above with reference to medical devices and procedures, it will be understood that the embodiments described herein can be applied to other systems in which objects are tracked and virtual representations are displayed on a display and/or systems in which multiple objects are displayed on a display within a virtual space, such as within a virtual 3D space. Thus, the present invention is not intended to be limited to the implementations shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
The present application claims priority benefit to U.S. Provisional Application No. 62/091,238, which is hereby incorporated herein by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3556079 | Omizo | Jan 1971 | A |
| 4058114 | Soldner | Nov 1977 | A |
| RE30397 | King | Sep 1980 | E |
| 4249539 | Vilkomerson et al. | Feb 1981 | A |
| 4294544 | Altschuler et al. | Oct 1981 | A |
| 4390025 | Takemura et al. | Jun 1983 | A |
| 4407294 | Vilkomerso | Oct 1983 | A |
| 4431006 | Trimmer et al. | Feb 1984 | A |
| 4567896 | Barnea et al. | Feb 1986 | A |
| 4583538 | Onik et al. | Apr 1986 | A |
| 4620546 | Aida et al. | Nov 1986 | A |
| 4671292 | Matzuk | Jun 1987 | A |
| 4839836 | Fonsalas | Jun 1989 | A |
| 4862873 | Yajima et al. | Sep 1989 | A |
| 4884219 | Waldren | Nov 1989 | A |
| 4899756 | Sonek | Feb 1990 | A |
| 4911173 | Terwillige | Mar 1990 | A |
| 4945305 | Blood | Jul 1990 | A |
| 5076279 | Arenson et al. | Dec 1991 | A |
| 5078140 | Kwoh | Jan 1992 | A |
| 5078142 | Siczek et al. | Jan 1992 | A |
| 5095910 | Powers | Mar 1992 | A |
| 5109276 | Nudelman et al. | Apr 1992 | A |
| 5158088 | Nelson et al. | Oct 1992 | A |
| 5161536 | Vikomerson et al. | Nov 1992 | A |
| 5193120 | Gamache et al. | Mar 1993 | A |
| 5209235 | Brisken et al. | May 1993 | A |
| 5249581 | Horbal et al. | Oct 1993 | A |
| 5251127 | Raab | Oct 1993 | A |
| 5261404 | Mick et al. | Nov 1993 | A |
| 5265610 | Darrow et al. | Nov 1993 | A |
| 5271400 | Dumoulin et al. | Dec 1993 | A |
| 5307153 | Maruyama et al. | Apr 1994 | A |
| 5309913 | Kormos et al. | May 1994 | A |
| 5323002 | Sampsell et al. | Jun 1994 | A |
| 5371543 | Anderson | Dec 1994 | A |
| 5383454 | Bucholz | Jan 1995 | A |
| 5394875 | Lewis et al. | Mar 1995 | A |
| 5411026 | Carol | May 1995 | A |
| 5433198 | Desai | Jul 1995 | A |
| 5433739 | Sluijter | Jul 1995 | A |
| 5443489 | Ben-Haim | Aug 1995 | A |
| 5446798 | Morita et al. | Aug 1995 | A |
| 5447154 | Cinquin et al. | Sep 1995 | A |
| 5452024 | Sampsell | Sep 1995 | A |
| 5457493 | Leddy et al. | Oct 1995 | A |
| 5474073 | Schwartz et al. | Dec 1995 | A |
| 5476096 | Olstad et al. | Dec 1995 | A |
| 5483961 | Kelly et al. | Jan 1996 | A |
| 5488431 | Gove et al. | Jan 1996 | A |
| 5489952 | Gove et al. | Feb 1996 | A |
| 5491510 | Gove | Feb 1996 | A |
| 5494039 | Onik et al. | Feb 1996 | A |
| 5503152 | Oakley et al. | Apr 1996 | A |
| 5505204 | Picot et al. | Apr 1996 | A |
| 5515856 | Olstad et al. | May 1996 | A |
| 5517990 | Kalfas et al. | May 1996 | A |
| 5526051 | Gove et al. | Jun 1996 | A |
| 5526812 | Dumoulin et al. | Jun 1996 | A |
| 5529070 | Augustine et al. | Jun 1996 | A |
| 5531227 | Schneider | Jul 1996 | A |
| 5532997 | Pauli | Jul 1996 | A |
| 5541723 | Tanaka | Jul 1996 | A |
| 5558091 | Acker et al. | Sep 1996 | A |
| 5568811 | Olstad | Oct 1996 | A |
| 5570135 | Gove et al. | Oct 1996 | A |
| 5579026 | Tabata | Nov 1996 | A |
| 5581271 | Kraemer | Dec 1996 | A |
| 5588948 | Takahashi et al. | Dec 1996 | A |
| 5608468 | Gove et al. | Mar 1997 | A |
| 5608849 | King, Jr. | Mar 1997 | A |
| 5611345 | Hibbeln | Mar 1997 | A |
| 5611353 | Dance et al. | Mar 1997 | A |
| 5612753 | Poradish et al. | Mar 1997 | A |
| 5625408 | Matsugu et al. | Apr 1997 | A |
| 5628327 | Unger et al. | May 1997 | A |
| 5629794 | Magel et al. | May 1997 | A |
| 5630027 | Venkateswar et al. | May 1997 | A |
| 5647361 | Damadian | Jul 1997 | A |
| 5647373 | Paltieli et al. | Jul 1997 | A |
| 5660185 | Shmulewitz et al. | Aug 1997 | A |
| 5662111 | Cosman | Sep 1997 | A |
| 5699444 | Palm | Dec 1997 | A |
| 5701898 | Adam et al. | Dec 1997 | A |
| 5701900 | Shehada et al. | Dec 1997 | A |
| 5726670 | Tabata et al. | Mar 1998 | A |
| 5728044 | Shan | Mar 1998 | A |
| 5758650 | Miller et al. | Jun 1998 | A |
| 5766135 | Terwilliger | Jun 1998 | A |
| 5784098 | Shoji et al. | Jul 1998 | A |
| 5792147 | Evans et al. | Aug 1998 | A |
| 5793701 | Wright et al. | Aug 1998 | A |
| 5797849 | Vesely et al. | Aug 1998 | A |
| 5807395 | Mulier et al. | Sep 1998 | A |
| 5810008 | Dekel et al. | Sep 1998 | A |
| 5817022 | Vesely | Oct 1998 | A |
| 5820554 | Davis et al. | Oct 1998 | A |
| 5820561 | Olstad et al. | Oct 1998 | A |
| 5829439 | Yokosawa et al. | Nov 1998 | A |
| 5829444 | Ferre et al. | Nov 1998 | A |
| 5851183 | Bodiolz | Dec 1998 | A |
| 5870136 | Fuchs et al. | Feb 1999 | A |
| 5891034 | Bucholz | Apr 1999 | A |
| 5920395 | Schulz | Jul 1999 | A |
| 5961527 | Whitmore, III et al. | Oct 1999 | A |
| 5967980 | Ferre et al. | Oct 1999 | A |
| 5967991 | Gardineer et al. | Oct 1999 | A |
| 5991085 | Rallison et al. | Nov 1999 | A |
| 6016439 | Acker | Jan 2000 | A |
| 6019724 | Gronningsaeter et al. | Feb 2000 | A |
| 6048312 | Ishrak et al. | Apr 2000 | A |
| 6064749 | Hirota et al. | May 2000 | A |
| 6091546 | Spitzer | Jul 2000 | A |
| 6095982 | Richards-Kortum et al. | Aug 2000 | A |
| 6099471 | Torp et al. | Aug 2000 | A |
| 6108130 | Raj | Aug 2000 | A |
| 6122538 | Sliwa, Jr. et al. | Sep 2000 | A |
| 6122541 | Cosman et al. | Sep 2000 | A |
| 6160666 | Rallison et al. | Dec 2000 | A |
| 6167296 | Shahidi | Dec 2000 | A |
| 6181371 | Maguire, Jr. | Jan 2001 | B1 |
| RE37088 | Olstad et al. | Mar 2001 | E |
| 6216029 | Paltieli | Apr 2001 | B1 |
| 6241725 | Cosman | Jun 2001 | B1 |
| 6245017 | Hashimoto et al. | Jun 2001 | B1 |
| 6246898 | Vesely et al. | Jun 2001 | B1 |
| 6248101 | Witmore, III et al. | Jun 2001 | B1 |
| 6261234 | Lin | Jul 2001 | B1 |
| 6341016 | Malione | Jan 2002 | B1 |
| 6348058 | Melken et al. | Feb 2002 | B1 |
| 6350238 | Olstad et al. | Feb 2002 | B1 |
| 6352507 | Torp et al. | Mar 2002 | B1 |
| 6379302 | Kessman et al. | Apr 2002 | B1 |
| 6385475 | Cinquin et al. | May 2002 | B1 |
| 6442417 | Shahidi et al. | Aug 2002 | B1 |
| 6447450 | Olsdat | Sep 2002 | B1 |
| 6456868 | Saito et al. | Sep 2002 | B2 |
| 6470207 | Simon et al. | Oct 2002 | B1 |
| 6471366 | Hughson et al. | Oct 2002 | B1 |
| 6477400 | Barrick | Nov 2002 | B1 |
| 6478793 | Cosman et al. | Nov 2002 | B1 |
| 6503195 | Keller et al. | Jan 2003 | B1 |
| 6511418 | Shahidi et al. | Jan 2003 | B2 |
| 6517485 | Torp et al. | Feb 2003 | B2 |
| 6518939 | Kikuchi | Feb 2003 | B1 |
| 6527443 | Vilsmeier | Mar 2003 | B1 |
| 6529758 | Shahidi | Mar 2003 | B2 |
| 6537217 | Steinar et al. | Mar 2003 | B1 |
| 6545706 | Edwards et al. | Apr 2003 | B1 |
| 6546279 | Bova et al. | Apr 2003 | B1 |
| 6551325 | Neubauer et al. | Apr 2003 | B2 |
| 6570566 | Yoshigahara | May 2003 | B1 |
| 6575969 | Rittman, III et al. | Jun 2003 | B1 |
| 6579240 | Bjaerum et al. | Jun 2003 | B2 |
| 6587711 | Alfano et al. | Jul 2003 | B1 |
| 6591130 | Shahidi | Jul 2003 | B2 |
| 6592522 | Bjaerum et al. | Jul 2003 | B2 |
| 6594517 | Nevo | Jul 2003 | B1 |
| 6597818 | Kumar et al. | Jul 2003 | B2 |
| 6604404 | Paltieli et al. | Aug 2003 | B2 |
| 6616610 | Steininger et al. | Sep 2003 | B2 |
| 6626832 | Paltieli et al. | Sep 2003 | B1 |
| 6652462 | Bjaerum et al. | Nov 2003 | B2 |
| 6669635 | Kessman et al. | Dec 2003 | B2 |
| 6676599 | Torp et al. | Jan 2004 | B2 |
| 6689067 | Sauer et al. | Feb 2004 | B2 |
| 6695786 | Wang et al. | Feb 2004 | B2 |
| 6711429 | Gilboa et al. | Mar 2004 | B1 |
| 6725082 | Sati et al. | Apr 2004 | B2 |
| 6733458 | Steins et al. | May 2004 | B1 |
| 6764449 | Lee et al. | Jul 2004 | B2 |
| 6766184 | Utzinger et al. | Jul 2004 | B2 |
| 6768496 | Bieger et al. | Jul 2004 | B2 |
| 6775404 | Pagoulatos et al. | Aug 2004 | B1 |
| 6782287 | Grzeszczuk et al. | Aug 2004 | B2 |
| 6783524 | Anderson et al. | Aug 2004 | B2 |
| 6827723 | Carson | Dec 2004 | B2 |
| 6863655 | Bjaerum et al. | Mar 2005 | B2 |
| 6873867 | Vilsmeier | Mar 2005 | B2 |
| 6875179 | Ferguson et al. | Apr 2005 | B2 |
| 6881214 | Cosman et al. | Apr 2005 | B2 |
| 6895268 | Rahn et al. | May 2005 | B1 |
| 6915150 | Cinquin et al. | Jul 2005 | B2 |
| 6917827 | Kienzle, III | Jul 2005 | B2 |
| 6923817 | Carson et al. | Aug 2005 | B2 |
| 6936048 | Hurst | Aug 2005 | B2 |
| 6947783 | Immerz | Sep 2005 | B2 |
| 6968224 | Kessman et al. | Nov 2005 | B2 |
| 6978167 | Dekel et al. | Dec 2005 | B2 |
| 7008373 | Stoianovici et al. | Mar 2006 | B2 |
| 7033360 | Cinquin et al. | Apr 2006 | B2 |
| 7072707 | Galloway, Jr. et al. | Jul 2006 | B2 |
| 7077807 | Torp et al. | Jul 2006 | B2 |
| 7093012 | Oltad et al. | Aug 2006 | B2 |
| 7110013 | Ebersole et al. | Sep 2006 | B2 |
| 7171255 | Holupka et al. | Jan 2007 | B2 |
| 7209776 | Leitner | Apr 2007 | B2 |
| 7245746 | Bjaerum et al. | Jul 2007 | B2 |
| 7248232 | Yamazaki et al. | Jul 2007 | B1 |
| 7261694 | Torp et al. | Aug 2007 | B2 |
| 7313430 | Urquhart et al. | Dec 2007 | B2 |
| 7331932 | Leitner | Feb 2008 | B2 |
| 7351205 | Szczech et al. | Apr 2008 | B2 |
| 7379769 | Piron et al. | May 2008 | B2 |
| 7385708 | Ackerman et al. | Jun 2008 | B2 |
| 7392076 | Moctezuma de la Barrera | Jun 2008 | B2 |
| 7398116 | Edwards | Jul 2008 | B2 |
| 7466303 | Yi et al. | Dec 2008 | B2 |
| 7480533 | Cosman et al. | Jan 2009 | B2 |
| 7505809 | Strommer et al. | Mar 2009 | B2 |
| 7588541 | Floyd et al. | Sep 2009 | B2 |
| 7596267 | Accomazzi et al. | Sep 2009 | B2 |
| 7652259 | Kimchy et al. | Jan 2010 | B2 |
| 7662128 | Salcudean et al. | Feb 2010 | B2 |
| 7678052 | Torp et al. | Mar 2010 | B2 |
| 7728868 | Razzaque et al. | Jun 2010 | B2 |
| 7747305 | Dean et al. | Jun 2010 | B2 |
| 7797032 | Martinelli et al. | Sep 2010 | B2 |
| 7798965 | Torp et al. | Sep 2010 | B2 |
| 7833168 | Taylor et al. | Nov 2010 | B2 |
| 7833221 | Voegele et al. | Nov 2010 | B2 |
| 7846103 | Cannon, Jr. et al. | Dec 2010 | B2 |
| 7876942 | Gilboa | Jan 2011 | B2 |
| 7889905 | Higgins et al. | Feb 2011 | B2 |
| 7912849 | Ohrn et al. | Mar 2011 | B2 |
| 7920909 | Lyon et al. | Apr 2011 | B2 |
| 7962193 | Edwards et al. | Jun 2011 | B2 |
| 7976469 | Bonde et al. | Jul 2011 | B2 |
| 8023712 | Ikuma et al. | Sep 2011 | B2 |
| 8038631 | Sanghvi et al. | Oct 2011 | B1 |
| 8041413 | Barbagli et al. | Oct 2011 | B2 |
| 8050736 | Piron et al. | Nov 2011 | B2 |
| 8052636 | Moll et al. | Nov 2011 | B2 |
| 8066644 | Sarkar et al. | Nov 2011 | B2 |
| 8073528 | Zhao et al. | Dec 2011 | B2 |
| 8086298 | Whitmore, III et al. | Dec 2011 | B2 |
| 8135669 | Olstad et al. | Mar 2012 | B2 |
| 8137281 | Huang et al. | Mar 2012 | B2 |
| 8147408 | Bunce et al. | Apr 2012 | B2 |
| 8152724 | Ridley et al. | Apr 2012 | B2 |
| 8167805 | Emery et al. | May 2012 | B2 |
| 8216149 | Oonuki et al. | Jul 2012 | B2 |
| 8221322 | Wang et al. | Jul 2012 | B2 |
| 8228028 | Schneider | Jul 2012 | B2 |
| 8257264 | Park et al. | Sep 2012 | B2 |
| 8296797 | Olstad et al. | Oct 2012 | B2 |
| 8340379 | Razzaque et al. | Dec 2012 | B2 |
| 8350902 | Razzaque et al. | Jan 2013 | B2 |
| 8482606 | Razzaque et al. | Jul 2013 | B2 |
| 8554307 | Razzaque et al. | Oct 2013 | B2 |
| 8585598 | Razzaque et al. | Nov 2013 | B2 |
| 8641621 | Razzaque et al. | Feb 2014 | B2 |
| 8670816 | Green et al. | Mar 2014 | B2 |
| 8690776 | Razzaque et al. | Apr 2014 | B2 |
| 8831310 | Razzaque et al. | Sep 2014 | B2 |
| 9107698 | Razzaque et al. | Aug 2015 | B2 |
| 9282947 | Razzaque et al. | Mar 2016 | B2 |
| 9364294 | Razzaque et al. | Jun 2016 | B2 |
| 9398936 | Razzaque et al. | Jul 2016 | B2 |
| 9659345 | Razzaque et al. | May 2017 | B2 |
| 9675319 | Razzaque et al. | Jun 2017 | B1 |
| 9901406 | State et al. | Feb 2018 | B2 |
| 9949700 | Razzaque et al. | Apr 2018 | B2 |
| 20010007919 | Shahidi | Jul 2001 | A1 |
| 20010016804 | Cunningham et al. | Aug 2001 | A1 |
| 20010041838 | Holupka et al. | Nov 2001 | A1 |
| 20010045979 | Matsumoto et al. | Nov 2001 | A1 |
| 20020010384 | Shahidi et al. | Jan 2002 | A1 |
| 20020032772 | Olstad et al. | Mar 2002 | A1 |
| 20020049375 | Strommer et al. | Apr 2002 | A1 |
| 20020077540 | Kienzie, III | Jun 2002 | A1 |
| 20020077543 | Grzeszczuk et al. | Jun 2002 | A1 |
| 20020103431 | Toker et al. | Aug 2002 | A1 |
| 20020105484 | Navab et al. | Aug 2002 | A1 |
| 20020135673 | Favalora et al. | Sep 2002 | A1 |
| 20020138008 | Tsujita et al. | Sep 2002 | A1 |
| 20020140814 | Cohen-Solal et al. | Oct 2002 | A1 |
| 20020156375 | Kessmam et al. | Oct 2002 | A1 |
| 20020198451 | Carson | Dec 2002 | A1 |
| 20030040743 | Cosman et al. | Feb 2003 | A1 |
| 20030073901 | Simon et al. | Apr 2003 | A1 |
| 20030135119 | Lee et al. | Jul 2003 | A1 |
| 20030163142 | Paltieli et al. | Aug 2003 | A1 |
| 20030164172 | Chumas et al. | Sep 2003 | A1 |
| 20030231789 | Willis et al. | Dec 2003 | A1 |
| 20040034313 | Leitner | Feb 2004 | A1 |
| 20040078036 | Keidar | Apr 2004 | A1 |
| 20040095507 | Bishop et al. | May 2004 | A1 |
| 20040116810 | Olstad | Jun 2004 | A1 |
| 20040147920 | Keidar | Jul 2004 | A1 |
| 20040152970 | Hunter et al. | Aug 2004 | A1 |
| 20040181144 | Cinquin et al. | Sep 2004 | A1 |
| 20040215071 | Frank et al. | Oct 2004 | A1 |
| 20040238732 | State et al. | Dec 2004 | A1 |
| 20040243146 | Chesbrough et al. | Dec 2004 | A1 |
| 20040243148 | Wasielewski | Dec 2004 | A1 |
| 20040249281 | Olstad | Dec 2004 | A1 |
| 20040249282 | Olstad | Dec 2004 | A1 |
| 20040254454 | Kockro | Dec 2004 | A1 |
| 20050010098 | Frigstad et al. | Jan 2005 | A1 |
| 20050085717 | Shahidi | Apr 2005 | A1 |
| 20050085718 | Shahidi | Apr 2005 | A1 |
| 20050090742 | Mine et al. | Apr 2005 | A1 |
| 20050107679 | Geiger et al. | May 2005 | A1 |
| 20050111733 | Fors et al. | May 2005 | A1 |
| 20050159641 | Kanai | Jul 2005 | A1 |
| 20050182316 | Burdette et al. | Aug 2005 | A1 |
| 20050192564 | Cosman et al. | Sep 2005 | A1 |
| 20050219552 | Ackerman et al. | Oct 2005 | A1 |
| 20050222574 | Giordano et al. | Oct 2005 | A1 |
| 20050251148 | Friedrich | Nov 2005 | A1 |
| 20060004275 | Vija et al. | Jan 2006 | A1 |
| 20060020204 | Serra et al. | Jan 2006 | A1 |
| 20060036162 | Shahidi et al. | Feb 2006 | A1 |
| 20060052792 | Boettiger et al. | Mar 2006 | A1 |
| 20060058609 | Olstad | Mar 2006 | A1 |
| 20060058610 | Olstad | Mar 2006 | A1 |
| 20060058674 | Olstad | Mar 2006 | A1 |
| 20060058675 | Olstad | Mar 2006 | A1 |
| 20060100505 | Viswanathan | May 2006 | A1 |
| 20060122495 | Kienzle | Jun 2006 | A1 |
| 20060184040 | Keller et al. | Aug 2006 | A1 |
| 20060193504 | Salgo et al. | Aug 2006 | A1 |
| 20060229594 | Francischelli et al. | Oct 2006 | A1 |
| 20060235290 | Gabriel et al. | Oct 2006 | A1 |
| 20060235538 | Rochetin et al. | Oct 2006 | A1 |
| 20060241450 | Da Silva et al. | Oct 2006 | A1 |
| 20060253030 | Altmann et al. | Nov 2006 | A1 |
| 20060253032 | Altmann et al. | Nov 2006 | A1 |
| 20060271056 | Terrill-Grisoni et al. | Nov 2006 | A1 |
| 20060282023 | Leitner | Dec 2006 | A1 |
| 20060293643 | Wallace et al. | Dec 2006 | A1 |
| 20070002582 | Burwell et al. | Jan 2007 | A1 |
| 20070016035 | Hashimoto | Jan 2007 | A1 |
| 20070032906 | Sutherland et al. | Feb 2007 | A1 |
| 20070073155 | Park et al. | Mar 2007 | A1 |
| 20070073455 | Oyobe et al. | Mar 2007 | A1 |
| 20070078346 | Park et al. | Apr 2007 | A1 |
| 20070167699 | Lathuiliere et al. | Jul 2007 | A1 |
| 20070167701 | Sherman | Jul 2007 | A1 |
| 20070167705 | Chiang et al. | Jul 2007 | A1 |
| 20070167771 | Olstad | Jul 2007 | A1 |
| 20070167801 | Webler et al. | Jul 2007 | A1 |
| 20070225553 | Shahidi | Sep 2007 | A1 |
| 20070239281 | Gotte et al. | Oct 2007 | A1 |
| 20070244488 | Metzger et al. | Oct 2007 | A1 |
| 20070255136 | Kjell et al. | Nov 2007 | A1 |
| 20070270718 | Rochetin et al. | Nov 2007 | A1 |
| 20070276234 | Kristofferson | Nov 2007 | A1 |
| 20070291000 | Liang et al. | Dec 2007 | A1 |
| 20080004481 | Bax et al. | Jan 2008 | A1 |
| 20080004516 | DiSilvestro et al. | Jan 2008 | A1 |
| 20080030578 | Razzaque et al. | Feb 2008 | A1 |
| 20080039723 | Suri et al. | Feb 2008 | A1 |
| 20080051910 | Kammerzell et al. | Feb 2008 | A1 |
| 20080091106 | Kim et al. | Apr 2008 | A1 |
| 20080114235 | Unal et al. | May 2008 | A1 |
| 20080146939 | McMorrow et al. | Jun 2008 | A1 |
| 20080161824 | McMillen | Jul 2008 | A1 |
| 20080183080 | Abraham | Jul 2008 | A1 |
| 20080200794 | Teichman et al. | Aug 2008 | A1 |
| 20080208031 | Kurpad et al. | Aug 2008 | A1 |
| 20080208081 | Murphy et al. | Aug 2008 | A1 |
| 20080214932 | Mollard et al. | Sep 2008 | A1 |
| 20080232679 | Hahn et al. | Sep 2008 | A1 |
| 20080287794 | Li et al. | Nov 2008 | A1 |
| 20080287805 | Li | Nov 2008 | A1 |
| 20080287837 | Makin et al. | Nov 2008 | A1 |
| 20090024030 | Lachaine et al. | Jan 2009 | A1 |
| 20090036902 | DeMaio et al. | Feb 2009 | A1 |
| 20090105597 | Abraham | Apr 2009 | A1 |
| 20090118613 | Krugman et al. | May 2009 | A1 |
| 20090118724 | Zvuloni et al. | May 2009 | A1 |
| 20090131783 | Jenkins et al. | May 2009 | A1 |
| 20090137907 | Takimoto et al. | May 2009 | A1 |
| 20090196480 | Nields et al. | Aug 2009 | A1 |
| 20090234369 | Bax et al. | Sep 2009 | A1 |
| 20090312629 | Razzaque et al. | Dec 2009 | A1 |
| 20100045783 | State et al. | Feb 2010 | A1 |
| 20100152570 | Navab | Jun 2010 | A1 |
| 20100185087 | Nields et al. | Jul 2010 | A1 |
| 20100198045 | Razzaque et al. | Aug 2010 | A1 |
| 20100208963 | Kruecker et al. | Aug 2010 | A1 |
| 20100268072 | Hall et al. | Oct 2010 | A1 |
| 20100268085 | Kruecker et al. | Oct 2010 | A1 |
| 20100296718 | Ostrovsky-Berman et al. | Nov 2010 | A1 |
| 20100298705 | Pelissier et al. | Nov 2010 | A1 |
| 20100305448 | Dagonnau et al. | Dec 2010 | A1 |
| 20100312121 | Guan | Dec 2010 | A1 |
| 20100331252 | Clements et al. | Dec 2010 | A1 |
| 20110043612 | Keller et al. | Feb 2011 | A1 |
| 20110046483 | Fuchs et al. | Feb 2011 | A1 |
| 20110046486 | Shin et al. | Feb 2011 | A1 |
| 20110057930 | Keller | Mar 2011 | A1 |
| 20110082351 | Razzaque et al. | Apr 2011 | A1 |
| 20110130641 | Razzaque et al. | Jun 2011 | A1 |
| 20110137156 | Razzaque | Jun 2011 | A1 |
| 20110201915 | Gogin et al. | Aug 2011 | A1 |
| 20110201976 | Sanghvi et al. | Aug 2011 | A1 |
| 20110230351 | Fischer et al. | Sep 2011 | A1 |
| 20110237947 | Boctor et al. | Sep 2011 | A1 |
| 20110238043 | Kleven | Sep 2011 | A1 |
| 20110251483 | Razzaque et al. | Oct 2011 | A1 |
| 20110274324 | Clements et al. | Nov 2011 | A1 |
| 20110282188 | Burnside et al. | Nov 2011 | A1 |
| 20110288412 | Deckman et al. | Nov 2011 | A1 |
| 20110295108 | Cox et al. | Dec 2011 | A1 |
| 20110301451 | Rohling | Dec 2011 | A1 |
| 20120035473 | Sanghvi et al. | Feb 2012 | A1 |
| 20120059260 | Robinson | Mar 2012 | A1 |
| 20120071759 | Hagy et al. | Mar 2012 | A1 |
| 20120078094 | Nishina et al. | Mar 2012 | A1 |
| 20120101370 | Razzaque et al. | Apr 2012 | A1 |
| 20120108955 | Razzaque et al. | May 2012 | A1 |
| 20120138658 | Ullrich et al. | Jun 2012 | A1 |
| 20120143029 | Silverstein et al. | Jun 2012 | A1 |
| 20120143055 | Cheng et al. | Jun 2012 | A1 |
| 20120165679 | Orome et al. | Jun 2012 | A1 |
| 20120237105 | Mielekamp | Sep 2012 | A1 |
| 20120259210 | Harhen et al. | Oct 2012 | A1 |
| 20130030286 | Alouani et al. | Jan 2013 | A1 |
| 20130044930 | Li et al. | Feb 2013 | A1 |
| 20130079770 | Kyle, Jr. et al. | Mar 2013 | A1 |
| 20130096497 | Duindam et al. | Apr 2013 | A1 |
| 20130132374 | Olstad et al. | May 2013 | A1 |
| 20130151533 | Udupa et al. | Jun 2013 | A1 |
| 20130178745 | Kyle et al. | Jul 2013 | A1 |
| 20130197357 | Green | Aug 2013 | A1 |
| 20130218024 | Boctor et al. | Aug 2013 | A1 |
| 20130249787 | Morimoto | Sep 2013 | A1 |
| 20140016848 | Razzaque et al. | Jan 2014 | A1 |
| 20140051987 | Kowshik et al. | Feb 2014 | A1 |
| 20140078138 | Martin et al. | Mar 2014 | A1 |
| 20140180074 | Green | Jun 2014 | A1 |
| 20140201669 | Liu et al. | Jul 2014 | A1 |
| 20140275760 | Lee et al. | Sep 2014 | A1 |
| 20140275810 | Keller et al. | Sep 2014 | A1 |
| 20140275997 | Chopra et al. | Sep 2014 | A1 |
| 20140343404 | Razzaque et al. | Nov 2014 | A1 |
| 20140350390 | Kudavelly et al. | Nov 2014 | A1 |
| 20160117857 | State | Apr 2016 | A1 |
| 20160166334 | Razzaque et al. | Jun 2016 | A1 |
| 20160196694 | Lindeman | Jul 2016 | A1 |
| 20160270862 | Fuchs et al. | Sep 2016 | A1 |
| 20170024903 | Razzaque | Jan 2017 | A1 |
| 20170065352 | Razzaque et al. | Mar 2017 | A1 |
| 20170128139 | Razzaque et al. | May 2017 | A1 |
| 20170323424 | Razzaque et al. | Nov 2017 | A1 |
| 20170348067 | Krimsky | Dec 2017 | A1 |
| 20170360395 | Razzaque et al. | Dec 2017 | A1 |
| 20180116731 | State et al. | May 2018 | A1 |
| 20180263713 | State | Sep 2018 | A1 |
| 20180289344 | Green et al. | Oct 2018 | A1 |
| Number | Date | Country |
|---|---|---|
| 7656896 | May 1997 | AU |
| 9453898 | Apr 1999 | AU |
| 1719601 | Jun 2001 | AU |
| 9036301 | Mar 2002 | AU |
| 2003297225 | Jul 2004 | AU |
| 2001290363 | Feb 2006 | AU |
| 0113882 | Jul 2003 | BR |
| 2420382 | Apr 2011 | CA |
| 60126798 | Oct 2007 | DE |
| 0 427 358 | May 1991 | EP |
| 1955284 | Aug 2008 | EP |
| S63-290550 | Nov 1988 | JP |
| H07-116164 | May 1995 | JP |
| 2005-058584 | Mar 2005 | JP |
| 2005-323669 | Nov 2005 | JP |
| 2009-517177 | Apr 2009 | JP |
| WO 96005768 | Feb 1996 | WO |
| WO 97015249 | May 1997 | WO |
| WO 97017014 | May 1997 | WO |
| WO1997029682 | Aug 1997 | WO |
| WO 9926534 | Jun 1999 | WO |
| WO 01039683 | Jun 2001 | WO |
| WO 03032837 | Apr 2003 | WO |
| WO 03034705 | Apr 2003 | WO |
| WO 03105289 | Dec 2003 | WO |
| WO 05010711 | Feb 2005 | WO |
| WO 07019216 | Feb 2007 | WO |
| WO 07067323 | Jun 2007 | WO |
| WO 07067323 | Sep 2007 | WO |
| WO 08017051 | Feb 2008 | WO |
| WO 09063423 | May 2009 | WO |
| WO 09094646 | Jul 2009 | WO |
| WO 10057315 | May 2010 | WO |
| WO 10096419 | Aug 2010 | WO |
| WO 11014687 | Feb 2011 | WO |
| WO 12169990 | Dec 2012 | WO |
| WO 13116240 | Aug 2013 | WO |
| WO 18080844 | May 2018 | WO |
| Entry |
|---|
| U.S. Appl. No. 11/828,826 including its ongoing prosecution history, including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents, filed Jul. 26, 2007, Keller et al. |
| “3D Laparoscope Technology,” http://www.inneroptic.com/tech_3DL.htm, copyright 2007 InnerOptic Technology, Inc. printed Sep. 19, 2007, 2 pages. |
| “Cancer Facts & Figures 2004,” www.cancer.org/downloads/STT/CAFF_finalPWSecured.pdf, copyright 2004 American Cancer Society, Inc., printed Sep. 19, 2007, 60 pages. |
| “David Laserscanner <-Latest News <-Institute for Robotics and Process Control <-Te . . . ,” http://www/rob.cs.tu-bs.de/en/news/david, printed Sep. 19, 2007, 1 page. |
| “Laser scanned 3d model Final” video, still image of video attached, http://www.youtube.com/watch?v+DaLgIgmoUf8, copyright 2007 YouTube, LLC, printed Sep. 19, 2007, 2 pages. |
| “Olympus Endoscopic Ultrasound System,” www.olympusamerica.com/msg_section/download_brochures/135_b—3gfum130.pdf, printed Sep. 20, 2007, 20 pages. |
| “Point Grey Research Inc.—Imaging Products—Triclops SDK Samples,” http://www.ptgrey.com/products/triclopsSDK/samples.asp, copyright 2007 Point Grey Research Inc., printed Sep. 19, 2007, 1 page. |
| “Robbins, Mike—Computer Vision Research—Stereo Depth Perception,” http://www.compumike.com/vision/stereodepth. php, copyright 2007 Michael F. Robbins, printed Sep. 19, 2007, 3 pages. |
| “RUE, Registered Ultrasound-Endoscope,” copyright 2007 InnerOptic Technology, Inc., 2 pages. |
| Advertisement, “Inspeck 3DC 3D Capturor,” Inspeck 3DC 3D Capturor (www.inspeck.com), 1998. |
| Advertisement, “Virtual 3D High Speed Non-Contact Surface Perception,” Virtual 3-D Technologies Corporation (www.virtual3dtech.com)., Dec. 21, 1998. |
| Advertisements, “Virtuoso,” Visual Interface, Inc. (www.visint.com), Dec. 21, 1998. |
| Akka, “Automatic Software Control of Display Parameters for Stereoscopic Graphics Images,” SPIE vol. 1669: Stereoscopic Displays and Applications III, pp. 31-38 (1992). |
| Ali et al., “Near Infrared Spectroscopy and Imaging to Probe Differences in Water Content in Normal and Cancer Human Prostate Tissues,” Technology in Cancer Research & Treatment; Oct. 2004; 3(5):491-497; Adenine Press. |
| Aylward et al., Analysis of the Parameter Space of a Metric for Registering 3D Vascular Images, in W. Niessen and M. Viergever (Eds.): MICCAI 2001, LNCS 2208, pp. 932-939, 2001. |
| Aylward et al., Registration and Analysis of Vascular Images, International Journal of Computer Vision 55(⅔), 123-138, 2003. |
| Aylward, et al., Intra-Operative 3D Ultrasound Augmentation, Proceedings of the IEEE International Symposium on Biomedical Imaging, Washington, Jul. 2002. |
| Azuma et al., “Improving Static and Dynamic Registration in an Optical See-Through HMD,” Paper Presented at SIGGRAPH '94 Annual Conference in Orlando, FL, 17 pages (1994). |
| Azuma, “A Survey of Augmented Reality,” Presence: Teleoperators and Virtual Environments 6, 4:1-48 (Aug. 1997). |
| Badler et al., “Simulating Humans: Computer Graphics, Animation, and Control,” Oxford University Press (1993). |
| Bajura, Michael et al., “Merging Virtual Objects with the Real World: Seeing Ultrasound Imagery within the Patient,” Computer Graphics, Proceedings of SIGGRAPH 1992, vol. 26(2), pp. 203-210, available from www.cs.unc.edu/˜fuchs/publications/MergVirtObjs92.pdf, printed Sep. 20, 2007, 8 pages. |
| Benavides et al., “Multispectral digital colposcopy for in vivo detection of cervical cancer,” Optics Express; May 19, 2003; 11(1 0) Optical Society of America; USA. |
| Beraldin, J.A. et al., “Optimized Position Sensors for Flying-Spot Active Triangulation Systems,” Proceedings of the Fourth International Conference on a 3-D Digital Imaging and Modeling (3DIM), Banff, Alberta, Canada, Oct. 6-10, 2003, pp. 334-341, NRC 47083, copyright 2003 National Research Council of Canada, http:/iit-iti.nrc-cnrc.gc.ca/iit-publications-iti/docs/NRC-47083.pdf, printed Sep. 19, 2007, 9 pages. |
| Billinghurst, M. et al., Research Directions in Handheld AR; Int. J. of Virtual Reality 5(2),51-58 (2006). |
| Blais, F., “Review of 20 Years of Range Sensor Development,” Journal of Electronic Imaging, 13(1): 231-240, Jan. 2004, NRC 46531, copyright 2004 National Research Council of Canada, http://iit-iti.nrc-cnrc.gc.ca/iit-publications-iti/docs/NRC-46531.pdf, printed Sep. 19, 2007, 14 pages. |
| Bouguet, Jean-Yves, “Camera Calibration Toolbox for Matlab,” www.vision.caltech.edu/bouguetj/calib_doc, printed Sep. 20, 2007, 5 pages. |
| Buxton et al.; “Colposcopically directed punch biopsy: a potentially misleading investigation,” British Journal of Obstetrics and Gynecology; Dec. 1991; 98:1273-1276. |
| Caines, Judy S. et al. Stereotaxic Needle Core Biopsy of Breast Lesions Using a Regular Mammographic Table with an Adaptable Stereotaxic Device, American Journal of Roentgenology, vol. 163, No. 2, Aug. 1994, pp. 317-321. Downloaded from www.ajrorline.org on Jul. 10, 2013. |
| Cancer Prevention & Early Detection Facts & Figures 2004; National Center for Tobacco-Free Kids; 2004; American Cancer Society; USA. |
| Cantor et al., “Cost-Effectiveness Analysis of Diagnosis and Management of Cervical Squamous Intraepithelial Lesions,” Diagnostic Strategies for SILs; Feb. 1998; 91(2):270-277. |
| Catalano et al. “Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinoma.” Abdom. Imaging, 25(6),2000, pp. 607-614. |
| Chiriboga et al., “Infrared Spectroscopy of Human Tissue. IV. Detection of Dysplastic and Neoplastic Changes of Human Cervical Tissue Via Infrared Microscopy,” Cellular and Molecular Biology; 1998; 44(1): 219-229. |
| Crawford, David E. et al., “Computer Modeling of Prostate Biopsy: Tumor Size and Location—Not Clinical Significance—Determine Cancer Detection,” Journal of Urology, Apr. 1998, vol. 159(4), pp. 1260-1264, 5 pages. |
| Deering, Michael “High Resolution Virtual Reality.” Proceedings of SIGGRAPH '92, Computer Graphics, 26(2), 1992, pp. 195-202. |
| Depiero et al., “3-D Computer Vision Using Structured Light: Design, Calibration and Implementation Issues,” The University of Tennessee, pp. 1-46, (1996). |
| Dodd, G.D. et al. “Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough.” Radiographies 20(1),2000, pp. 9-27. |
| Drascic et al., “Perceptual Issues in Augmented Reality,” SPIE vol. 2653: Stereoscopic Displays and Virtual Reality Systems III, pp. 123-134 (Feb. 1996). |
| Dumoulin, C.L. et al, Real-Time Position Monitoring of Invasive Devices Using Magnetic Resonance, Magnetic Resonance in Medicine, vol. 29, Issue 3, Mar. 1993, pp. 411-415. |
| Fahey et al., “Meta-analysis of Pap Test Accuracy; American Journal of Epidemiology,” 1995 141(7):680-689; The John Hopkins University School of Hvgiene and Public Health; USA. |
| Foxlin et al., “An Inertial Head-Orientation Tracker with Automatic Drift Compensation for Use with HMD's,” Proceedings of the 1994 Virtual Reality Software and Technology Conference, Aug. 23-26, 1994, Singapore, pp. 159-173 (1994). |
| Fronheiser et al., Real-Time 3D Color Doppler for Guidance of Vibrating Interventional Devices, IEEE Ultrasonics Symposium, pp. 149-152 (2004). |
| Fuchs, Henry et al. “Augmented Reality Visualization for Laparoscopic Surgery,” Proceedings of Medical Image Computing and Computer-Assisted Intervention (MICCAI) 1998, pp. 934-943, available from www.cs.unc.edu/˜fuchs/publications/AugRealVis_LaparoSurg98.pdf, printed Sep. 20, 2007, 10 pages. |
| Fuchs, et al.: “Optimizing a Head-Tracked Stereo Display System to Guide Hepatic Tumor Ablation,” Departments of Computer Sciences and Radiology, and School of Medicine, University of North Carolina at Chapel Hill; InnerOptic Technology, Inc. 2008. |
| Fuchs, et al.: “Virtual Environments Technology to Aid Needle Biopsies of the Breast,” Health Care in the Information Age, Ch. 6, pp. 60-61, Presented in San Diego, Jan. 17-20, 1996, published by IOS Press and Ohmsha Feb. 1996. |
| Fuhrmann A. et al., Comprehensive calibration and registration procedures for augmented reality; Proc. Eurographics Workshop on Virtual Environments 2001,219--228 (2001). |
| Garrett, William F. et al., “Real-Time Incremental Visualization of Dynamic Ultrasound Volumes Using Parallel BSP Trees,” Proceedings of IEEE Visualization 1996, pp. 235-240, available from www.cs.unc.edu/˜andrei/pubs/1996_VIS_dualBSP_Mac.pdf, printed Sep. 20, 2007, 7 pages. |
| Georgakoudi et al., “Trimodal spectroscopy for the detection and characterization of cervical precancers in vivo,” American Journal of Obstetrics and Gynecology; Mar. 2002; 186(3):374-382; USA. |
| StereoMirror Technology Webpage, http://www.planar.com/products/flatpanel_monitors/stereoscopic/ (Printed Dec. 29, 2011). |
| Herline et al., Surface Registration for Use in Interactive, Image-Guided Liver Surgery, Computer Aided Surgery 5:11-17 (2000). |
| Holloway, R.; Registration Error Analysis for Augmented Reality; Presence: Teleoperators and Virtual Environments 6(4), 413--432 (1997). |
| Hornung et al., “Quantitative near-infrared spectroscopy of cervical dysplasia in vivo,” Human Reproduction; 1999; 14(11):2908-2916; European Society of Human Reproduction and Embryology. |
| Howard, M.D., et al.: “An Electronic Device for Needle Placement during Sonographically Guided Percutaneous Intervention”, Radiology 2001; 218:905-911. |
| InnerAim Brochure; 3D Visualization Software for Simpler, Safer, more Precise Aiming, Published no earlier than Apr. 1, 2010. |
| InVision System Brochure; A “GPS” for Real-Time 3D Needle Visualization & Guidance, Published no earlier than Mar. 1, 2008. |
| InVision User Manual; Professional Instructions for Use, Published no earlier than Dec. 1, 2008. |
| Jacobs, Marco C. et al., “Managing Latency in Complex Augmented Reality Systems,” ACM SIGGRAPH Proceedings of the Symposium of Interactive 3D Graphics 1997, pp. 49-54, available from www.cs.unc.edu/˜us/Latency//ManagingRelativeLatency.html, printed Sep. 20, 2007, 12 pages. |
| Jolesz, Ferenc A, M.D., et al. MRI-Guided Laser-Induced Interstitial Thermotherapy: Basic Principles, SPIE Institute on Laser-Induced Interstitial Thermotherapy (L1TT), Jun. 22-23, 1995, Berlin, Germany. |
| Kadi, A Majeed, et al., Design and Simulation of an Articulated Surgical Arm for Guiding Sterotactic Neurosurgery, SPIE vol. 1708 Applications of Artificial Intelligence X: Machine Vision and Robotics (1992). Downloaded from: http://proceedings.spiedigitallibrary.org/ on Jul. 11, 2013. |
| Kanbara et al., “A Stereoscopic Video See-through Augmented Reality System Based on Real-time Vision-Based Registration,” Nara Institute of Science and Technology, pp. 1-8 (2000). |
| Kato, Amami, et al., A frameless, armless navigational system for computer-assisted neurosurgery, Journal of Neurosurgery, vol. 74, No. 5, May 1991, pp. 845-849. |
| Keller et al., “What is it in Head Mounted Displays (MDs) that really make them all so terrible?,” pp. 1-8 (1998). |
| Lass, Amir, “Assessment of Ovarian Reserve,” Human Reproduction, 2004, vol. 19(3), pp. 467-469, available from http://humrep.oxfordjournals.orgcgi/reprint/19/3/467, printed Sep. 20, 2007, 3 pages. |
| Lee, et al., “Modeling Real Objects Using Video See-Through Augmented Reality,” Proceedings of the Second International Symposium on Mixed Reality, ISMR 2001, pp. 19-26 (Mar. 14-15, 2001). |
| Lee et al., “Modeling Real Objects Using Video See-Through Augmented Reality,” Presence, 11(2):144-157 (Apr. 2002). |
| Leven et al., DaVinci Canvas: A Telerobotic Surgical System with Integrated, Robot-Assisted, Laparoscopic Ultrasound Capability, in J. Duncan and G. Gerig (Eds.): MICCAI 2005, LNCS 3749, pp. 811-818, 2005. |
| Levy, et al., An Internet-Connected, Patient Specific, Deformable Brain Atlas Integrated into a Surgical Navigation System, Journal of Digital Imaging, vol. 10, No. 3. Suppl. 1 Aug. 1997: pp. 231-237. |
| Livingston, Mark A. et al., “Magnetic Tracker Calibration for Improved Augmented Reality Registration,” Presence: Teleoperators and Virtual Environments, 1997, vol. 6(5), pp. 532-546, available from www.cs.unc.edu/˜andrei/pubs/1997_Presence_calibr.pdf, printed Sep. 20, 2007, 14 pages. |
| Matsunaga et al., “The Effect of the Ratio Difference of Overlapped Areas of Stereoscopic Images on each Eye in a Teleoperalion,” Stereoscopic Displays and Virtual Reality Systems VII, Proceedings of SPIE, 3957:236-243 (2000). |
| Meehan, Michael et al., “Effect of Latency on Presence in Stressful Virtual Environment,” Proceedings of IEEE Virtual Reality 2003, pp. 141-148, available from http://www.cs.unc.edu/˜eve/pubs.html, printed Sep. 20, 2007, 8 pages. |
| Milgram et al., “Adaptation Effects in Stereo due to Online Changes in Camera Configuration,” SPIE vol. 1669-13, Stereoscopic Displays and Applications III, 17 pages (1992). |
| Mitchell et al., “Colposcopy for the Diagnosis of Squamous Intraepithelial lesions: A metaanalysis,” Obstetrics and Gynecology; Apr. 1998; 91(4):626-631. |
| Nakamoto et al., 3D Ultrasound System Using a Magneto-optic Hybrid Tracker for Augmented Reality Visualization in Laparoscopic Liver Surgery, in T. Dohi and R. Kikinis (Eds.): MICCAI 2002, LNCS 2489, pp. 148-155, 2002. |
| Nordstrom et al., “Identification of Cervical Intraepithelial Neoplasia (CIN) Using UV-Excited Fluorescence and Diffuse-Reflectance Tissue Spectroscopy,” Lasers in Surgery and Medicine; 2001; 29; pp. 118-127; Wiley-Liss, Inc. |
| Ohbuchi et al. “An Incremental Volume Rendering Algorithm for Interactive 3D Ultrasound Imaging”, UNC-CH Computer Science Technical Report TR91-003, (1991). |
| Ohbuchi et al., “Incremental Volume Reconstruction and Rendering for 3D Ultrasound Imaging,” Visualization in Biomedical Computing, SPIE Proceedings, pp. 312-323, (Oct. 13, 1992). |
| Ohbuchi, “Incremental Acquisition and Visualization of 3D Ultrasound Images,” Ph.D. Dissertation, UNC-CH Computer Science Technical Report TR95--023, (1993). |
| Progue, Brian W. et al., “Analysis of acetic acid-induced whitening of high-grade squamous intraepitheliallesions,” Journal of Biomedical Optics; Oct. 2001; 6(4):397-403. |
| Raij, A.B., et al., Comparing Interpersonal Interactions with a Virtual Human to Those with a Real Human; IEEE Transactions on Visualization and Computer Graphics 13(3), 443-457 (2007). |
| Raz et al, Real-Time Magnetic Resonance Imaging—Guided Focal Laser Therapy in Patients with Low-Risk Prostate Cancer, European Urology 58, pp. 173-177. Mar. 12, 2010. |
| Robinett et al., “A Computational Model for the Stereoscopic Optics of a Head-Mounted Display,” SPIE vol. 1457, Stereoscopic Displays and Applications II, pp. 140-160 (1991). |
| Rolland et al., Towards Quantifying Depth and Size Perception in Virtual Environments, Presence: Teleoperators and Virtual Environments, Winter 1995, vol. 4, Issue 1, pp. 1-21 and 24-49. |
| Rosenthal, Michael et al., “Augmented Reality Guidance for Needle Biopsies: An Initial Randomized, Controlled Trial in Phantoms,” Proceedings of Medical Image Analysis, Sep. 2002, vol. 6(3), pp. 313-320, available from www.cs.unc.edu/˜fuchs/publications/AugRealGuida_NeedleBiop02.pdf, printed Sep. 20, 2007, 8 pages. |
| Rosenthal, Michael et al., “Augmented Reality Guidance for Needle Biopsies: A Randomized, Controlled Trial in Phantoms,” Proceedings of MICCAI 2001, eds. W. Niessen and M. Viergever, Lecture Notes in Computer Science, 2001, vol. 2208, pp. 240-248, available from www.cs.unc.edu/˜us/AugmentedRealityAssistance.pdf, printed Sep. 20, 2007, 9 pages. |
| Screenshots from video produced by the University of North Carolina, produced circa 1992. |
| State et al., “Case Study: Observing a Volume Rendered Fetus within a Pregnant Patient,” Proceedings of IEEE Visualization 1994, pp. 364-368, available from www.cs.unc.edu/˜fuchs/publications/cs-ObservVolRendFetus94.pdf, printed Sep. 20, 2007, 5 pages. |
| State et al., “Interactive Volume Visualization on a Heterogeneous Message-Passing Multicomputer,” Proceedings of 1995 Symposium on Interactive 3D Graphics, 1995, pp. 69-74, 208, available from www.cs.unc.edu/˜andrei/pubs/1995_I3D_vol2_Mac.pdf, printed Sep. 20, 2007. |
| State et al., “Simulation-Based Design and Rapid Prototyping of a Parallax-Free, Orthoscopic Video See-Through Head-Mounted Display,” Proceedings of International Symposium on Mixed and Augmented Reality (ISMAR) 2005, available from www.cs.unc.edu/˜andrei/pubs/2005_ISMAR_VSTHMD_design.pdf, printed Sep. 20, 2007, 4 pages. |
| State et al., “Stereo Imagery from the UNC Augmented Reality System for Breast Biopsy Guidance” Proc. Medicine Meets Virtual Reality (MMVR) 2003 (Newport Beach, CA, Jan. 22-25, 2003). |
| State et al., “Superior Augmented Reality Registration by Integrating Landmark Tracking and Magnetic Tracking,” ACM SIGGRAPH Computer Graphics, Proceedings of SIGGRAPH 1996, 10 pages (Aug. 1996). |
| State et al., “Technologies for Augmented Reality Systems: Realizing Ultrasound-Guided Needle Biopsies,” Proc. SIGGRAPH 96 (New Orleans, LA, Aug. 4-9, 1996). In Computer Graphics Proceedings, Annual Conference Series, 1996, ACM SIGGRAPH, pp. 439-446. |
| State, Andrei “Exact Eye Contact with Virtual Humans.” Proc. IEEE International Workshop on Human Computer Interaction 2007 (Rio de Janeiro, Brazil, Oct. 20, 2007), pp. 138-145. |
| State, et al.: Contextually Enhanced 3D Visualization for Multi-Born Tumor Ablation Guidance, Departments of Computer Science and Radiology, and School of Medicine, University of North Carolina at Chapel Hill; InnerOptic Technology, Inc. 2008, Chapel Hill, NC, pp. 70-77. |
| Symons et al., “What are You Looking at? Acuity for Triadic Eye Gaze,” J. Gen. Psychology 131(4), pp. 451-469 (2004). |
| Takacs et al., “The Virtual Human Interface: A Photorealistic Digital Human,” IEEE Computer Graphics and Applications 23(5), pp. 38-45 (2003). |
| Takagi et al., “Development of a Stereo Video See-through HMD for AR Systems,” IEEE, pp. 68-77 (2000). |
| Takayama et al., “Virtual Human with Regard to Physical Contact and Eye Contact,” Entertaining Computing 2005, LNCS, vol. 3711, pp. 268-278 (2005). |
| Ultraguide 1000 System, Ultraguide, www.ultraguideinc.com, 1998. |
| Van Staveren et al., “Light Scattering in Intralipid-10% in the wavelength range of 400-1100 nm,” Applied Optics; Nov. 1991; 30(31):4507-4514. |
| Viola et al., “Alignment by Maximization of Mutual Information,” International Journal of Computer Vision, vol. 24, No. 2, pp. 1-29 (1997). |
| Viola, Paul A., Alignment by Maximization of Mutual Information, Ph.D. Dissertation, MIT-Artificial Intelligence Laboratory Technical Report No. 1548 (Jun. 1995). |
| Ware et al., “Dynamic Adjustment of Stereo Display Parameters,” IEEE Transactions on Systems, Many and Cybernetics, 28(1):1-19 (1998). |
| Watson et al., “Using Texture Maps to Correct for Optical Distortion in Head-Mounted Displays,” Proceedings of the Virtual Reality Annual Symposium '95, IEEE, pp. 1-7 (1995). |
| Welch, Hybrid Self-Tracker: An Inertial/Optical Hybrid Three-Dimensional Tracking System, University of North Carolina Chapel Hill Department of Computer Science, TR 95-048 (1995). |
| Yinghui et al., Real-Time Deformation Using Modal Analysis on Graphics Hardware, Graphite 2006, Kuala Lumpur, Malaysia, Nov. 29-Dec. 2, 2006. |
| Zitnick et al., “Multi-Base Stereo Using Surface Extraction,” Visual Interface Inc., (Nov. 24, 1996). |
| U.S. Appl. No. 15/041,868 including its ongoing prosecution history, including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents, filed Feb. 11, 2016, Fuchs et al. |
| U.S. Appl. No. 15/068,323 including its ongoing prosecution history, including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents, filed Mar. 11, 2016, Razzaque et al. |
| U.S. Appl. No. 15/415,398 including its ongoing prosecution history, including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents, filed Jan. 25, 2017, State et al. |
| U.S. Appl. No. 15/598,616 including its ongoing prosecution history, including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents, filed May 18, 2017, Razzaque et al. |
| “Sony Introduces Head-Mounted Display for Endoscopic Surgery” (Jul. 23, 2013), retrieved Sep. 27, 2016, 5 pages, available at http://www.medgaget.com/2013/07/sony-introduces-head-mounted-display-for-endoscopic-surgery.html. |
| “Sony Introduces ‘head-mount image processing unit’ for endoscopic image display” (Jul. 23, 2013), retrieved Sep. 27, 2016, 8 pages, available at http://www.sony.net/SonyInfo/News/Press/201307/13-085E/index.html. |
| U.S. Appl. No. 15/799,639 including its ongoing history, including without limiation Office Actions, Amendments, Remarks, and any other potentially relevant documents, dated Oct. 31, 2017, Green et al. |
| Obround Agreements and Conferences Overview, various dates, 3 pages. |
| U.S. Appl. No. 15/882,709, filed Jan. 29, 2018, State et al. |
| U.S. Appl. No. 15/995,059, filed Apr. 17, 2018, Kohli et al. |
| Press Release: Pathfinder and InnerOptic Announce Technology Integration to Enhance Visualization and Outcomes in Liver Surgery, Published Mar. 6, 2013. |
| “InnerOptic's AIM System Receives DA 501(K) Clearance”, InnerOptic Technology, Inc., Sep. 18, 2012. |
| Ohnesorge, Lauren K., “InnerOptic technology wins FDA approval”, Triangle Business Journal, Sep. 19, 2012. |
| “AIM 3D Needle Placement Software from InnerOptic”, Medgadget, Sep. 21, 2012. |
| U.S. Appl. No. 16/052,289 including its ongoing prosecution history, including without limitation Office Actions, Amendments, Remarks, and any other potentially relevant documents, dated Aug. 1, 2018, Kohli et al. |
| AIM Section 5: 510k Summary, submitted by InnerOptic Technology, Inc., in 5 pages, submission date May 17, 2012. |
| Lindeman, A Low-Cost, Low-latency Approach to Dynamic Immersion in Occlusive Head-Mounted Displays, University of Canterbury, WPI,- Poster from IEEE VR 2016, Mar. 19-23, 2016. |
| Number | Date | Country | |
|---|---|---|---|
| 20160166336 A1 | Jun 2016 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62091238 | Dec 2014 | US |
